var title_f16_50_17184="PA stump thrombus CT";
var content_f16_50_17184=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F80246&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F80246&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Postpneumonectomy complication: Thrombus in the pulmonary artery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 227px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest CT after right-sided pneumonectomy shows a thrombus in the right pulmonary artery stump (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Richard Irwin, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_50_17184=[""].join("\n");
var outline_f16_50_17184=null;
var title_f16_50_17185="Circadian pattern AMI SCD";
var content_f16_50_17185=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F56626%7ECARD%2F59140&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F56626%7ECARD%2F59140&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 509px\">",
"   <div class=\"ttl\">",
"    Circadian pattern of nonfatal myocardial infarction and sudden death",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 489px; height: 526px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A meta-analysis was performed using trials that reported the timing for an acute myocardial infarction (N=66,635 patients) and sudden death (N=19,390 patients). An excess number of infarctions and sudden deaths occurred in the morning between the hours of 6 am and 12 pm, indicating a circadian pattern to their occurrence.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Kangro, T, Henriksen, E, Jonason, T, et al. Am J Cardiol 1997; 79:1507.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 557px\">",
"   <div class=\"ttl\">",
"    Circadian variation in unstable angina and non-Q wave myocardial infarction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 537px; height: 297px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Prospective analysis of patients entered into the TIMI III registry shows that there is a circadian variation in the onset of pain in patients with unstable angina and non-Q wave myocardial infarction (AMI); the greatest number of patients experience the onset of pain between 6 am and 12 pm.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from Cannon, CP, McCabe, CH, Stone, PH, et al, for the TIMI III Registry and TIMI IIIB Investigators, AM J Cardiol 1997; 79:253.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_50_17185=[""].join("\n");
var outline_f16_50_17185=null;
var title_f16_50_17186="Fracture geometry";
var content_f16_50_17186=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F61031&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F61031&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fracture geometry",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 442px; height: 334px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Fracture geometry refers to the orientation of the fracture to the long axis of the bone.",
"    <br>",
"     Fractures are classified as:",
"     <ul>",
"      <li>",
"       Transverse - perpendicular to long axis of bone",
"      </li>",
"      <li>",
"       Oblique - tangential to long axis of bone",
"      </li>",
"      <li>",
"       Spiral - tangential and spiraling around the shaft",
"      </li>",
"      <li>",
"       Longitudinal - parallel to long axis of bone",
"      </li>",
"      <li>",
"       A combination of two or more of the above",
"      </li>",
"     </ul>",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_50_17186=[""].join("\n");
var outline_f16_50_17186=null;
var title_f16_50_17187="Onychomadesis";
var content_f16_50_17187=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85705&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85705&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Nail plate detachment from the matrix area (onychomadesis)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_50_17187=[""].join("\n");
var outline_f16_50_17187=null;
var title_f16_50_17188="Superficial basal cell carcinoma";
var content_f16_50_17188=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F57990&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F57990&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Superficial basal cell carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This erythematous, slightly scaly patch is representative of a superficial basal cell carcinoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_50_17188=[""].join("\n");
var outline_f16_50_17188=null;
var title_f16_50_17189="Burns from a hot coffee mug in leprosy";
var content_f16_50_17189=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F67856&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F67856&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 500px\">",
"   <div class=\"ttl\">",
"    Ulcers from burns due to a hot coffee mug in a leprosy patient",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 480px; height: 423px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_50_17189=[""].join("\n");
var outline_f16_50_17189=null;
var title_f16_50_17190="Insulin glargine: Pediatric drug information";
var content_f16_50_17190=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Insulin glargine: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?33/30/34279?source=see_link\">",
"    see \"Insulin glargine: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?5/34/5669?source=see_link\">",
"    see \"Insulin glargine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F2114346\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Lantus&reg;;",
"     </li>",
"     <li>",
"      Lantus&reg; Solostar&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F2186124\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Lantus&reg;;",
"     </li>",
"     <li>",
"      Lantus&reg; OptiSet&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F991016\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antidiabetic Agent, Parenteral",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Insulin, Long-Acting",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F991017\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?33/30/34279?source=see_link\">",
"      see \"Insulin glargine: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Insulin glargine is a long-acting insulin administered by SubQ injection. Insulin glargine is approximately equipotent to human insulin, but has a slower onset, no pronounced peak, and a longer duration of activity. Changing the basal insulin component from another insulin to insulin glargine can be done on a unit-to-unit basis. Insulin requirements vary dramatically between patients and dictates frequent monitoring and close medical supervision. See Insulin Regular for additional information.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      General insulin dosing:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Type 1 diabetes mellitus:",
"     </b>",
"     Children, Adolescents, and Adults:",
"     <b>",
"      Note:",
"     </b>",
"     Multiple daily doses are utilized and guided by blood glucose monitoring. Combinations of insulin formulations are commonly used. The daily doses presented below are expressed as the",
"     <b>",
"      total units/kg/day of all insulin formulations",
"     </b>",
"     used. Insulin glargine must be used in combination with a short-acting insulin.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <b>",
"      Usual maintenance range:",
"     </b>",
"     SubQ: 0.5-1 unit/kg/day in divided doses. An estimate of anticipated needs may be based on body weight and/or activity factors as follows:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Adolescents: May require &le;1.2 units/kg/day during growth spurts",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Nonobese: 0.4-0.6 units/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Obese: 0.8-1.2 units/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <b>",
"      Adjustment of dose:",
"     </b>",
"     Dosage must be titrated to achieve glucose control and avoid hypoglycemia. Adjust dose to maintain premeal and bedtime glucose in target range. Since combinations of agents are frequently used, dosage adjustment must address the individual component of the insulin regimen which most directly influences the blood glucose value in question, based on the known onset and duration of the insulin component.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Insulin glargine-specific dosing:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Type 1 diabetes mellitus:",
"     </b>",
"     Children &ge;6 years, Adolescents, and Adults: SubQ: Initial dose: Approximately one-third of the total daily insulin requirement; a rapid-acting or short-acting insulin should also be used.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Type 2 diabetes mellitus:",
"     </b>",
"     Adults: SubQ: Initial basal insulin dose: 10 units (",
"     <b>",
"      or",
"     </b>",
"     0.2 units/kg) once daily in the evening; may also administer total daily dose in 2 divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Type 1 or type 2 diabetes; previously receiving basal insulin plus bolus insulin (eg, NPH + regular insulin):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Children &lt;6 years: SubQ: Limited data; 40% of the established total daily insulin requirement; this resulted in a reduction in hypoglycemic episodes in 35 nonobese  preschool-aged children (age range: 2.6-6.3 years) when used in conjunction with a rapid-acting insulin prior to meals (Alemzadeh, 2005).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Children &ge;6 years and Adults: SubQ:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Converting from once-daily NPH insulin: May be substituted on an equivalent unit-per-unit basis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Converting from twice-daily NPH insulin: Initial dose: Use 80% of the total daily dose of NPH (eg, 20% reduction); administer once daily; adjust dosage according to patient response",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosage adjustment in renal impairment:",
"     </b>",
"     Insulin requirements are reduced due to changes in insulin clearance or metabolism.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F2104245\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lantus&reg;: 100 units/mL (3 mL) [cartridge]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lantus&reg;: 100 units/mL (10 mL) [vial]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lantus&reg; Solostar&reg;: 100 units/mL (3 mL) [prefilled pen]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F2114347\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F2529656\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Parenteral: SubQ: Administer into the subcutaneous fat of the thighs, arms, buttocks, or abdomen, with sites rotated. Cold injections should be avoided. Administer once daily, at any time of day, but at the same time each day. Do not mix with any other insulin or solution.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F2110688\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Compatibility in syringe: Incompatible:",
"     </b>",
"     Insulin aspart, insulin detemir, insulin glulisine, insulin lispro, insulin NPH, insulin regular.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F2984568\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Store unopened containers or cartridges in refrigerator at 2&deg;C to 8&deg;C (36&deg;F to 46&deg;F); do not freeze; protect from direct heat or light. Once opened (in use), vials may be stored in refrigerator or at room temperature for up to 28 days. Cartridges (in use; inserted into OptiClik&trade; delivery system) should not be refrigerated; store below 30&deg;C (86&deg;F) away from direct heat or light; discard after 28 days. May",
"     <b>",
"      not",
"     </b>",
"     be mixed with any other insulin or solution.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F2529652\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of type 1 diabetes mellitus (insulin dependent, IDDM); type 2 diabetes mellitus (noninsulin dependent, NIDDM) requiring basal (long-acting) insulin to control hyperglycemia",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F2114344\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Insulin glargine may be confused with insulin glulisine",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Lantus&reg; may be confused with latanoprost, Latuda&reg;, Xalatan&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drugs which have a heightened risk of causing significant patient harm when used in error.",
"       <b>",
"        <i>",
"         Due to the number of insulin preparations, it is essential to identify/clarify the type of insulin to be used.",
"        </i>",
"       </b>",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Administration issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Insulin glargine is a clear solution, but it is NOT intended for I.V. or I.M. administration.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Cross-contamination may occur if insulin pens are shared among multiple patients. Steps should be taken to prohibit sharing of insulin pens.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Lantus [U.S., Canada, and multiple international markets] may be confused with Lanvis brand name for thioguanine [Canada and multiple international markets]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F2110686\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Primarily symptoms of hypoglycemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiovascular: Pallor, palpitation, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Fatigue, headache, hypothermia, loss of consciousness, mental confusion",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Redness, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hypoglycemia, hypokalemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Hunger, nausea, numbness of mouth",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Atrophy or hypertrophy of SubQ fat tissue; edema, itching, pain or warmth at injection site; stinging",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Muscle weakness, paresthesia, tremor",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Transient presbyopia or blurred vision",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Anaphylaxis, diaphoresis, local and/or systemic hypersensitivity reactions",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F2984565\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Hypersensitivity insulin glargine or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F2984566\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution and adjust dosage in patients with renal impairment; use with caution and monitor closely in patient with hepatic impairment.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F2529653\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypoglycemia is the most common adverse effect of insulin. The timing of hypoglycemia differs among various insulin formulations. Any change of insulin should be made cautiously; changing manufacturers, type, and/or method of manufacture may result in the need for a change of dosage. Hypoglycemia may result from increased work or exercise without eating; use of long-acting insulin preparations (insulin glargine, Ultralente&reg;) with regular insulin may delay recovery from hypoglycemia.",
"     <b>",
"      Not for I.V. administration",
"     </b>",
"     or use in insulin infusion pumps.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F2114383\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F2114382\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antidiabetic Agents (Thiazolidinedione): Insulin may enhance the fluid-retaining effect of Antidiabetic Agents (Thiazolidinedione).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: May enhance the hypoglycemic effect of Insulin.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levobunolol; Metipranolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Orally Inhaled): May diminish the hypoglycemic effect of Antidiabetic Agents. In some instances, corticosteroid-mediated HPA axis suppression has led to episodes of acute adrenal crisis, which may manifest as enhanced hypoglycemia, particularly in the setting of insulin or other antidiabetic agent use.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): May diminish the hypoglycemic effect of Antidiabetic Agents. In some instances, corticosteroid-mediated HPA axis suppression has led to episodes of acute adrenal crisis, which may manifest as enhanced hypoglycemia, particularly in the setting of insulin or other antidiabetic agent use.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Edetate CALCIUM Disodium: May enhance the hypoglycemic effect of Insulin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Edetate Disodium: May enhance the hypoglycemic effect of Insulin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypoglycemic Properties): May enhance the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypoglycemic Agents: May enhance the adverse/toxic effect of other Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Loop Diuretics: May diminish the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Luteinizing Hormone-Releasing Hormone Analogs: May diminish the therapeutic effect of Antidiabetic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pegvisomant: May enhance the hypoglycemic effect of Antidiabetic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinolone Antibiotics: Insulin may enhance the hyperglycemic effect of Quinolone Antibiotics. Insulin may enhance the hypoglycemic effect of Quinolone Antibiotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: May enhance the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: May enhance the hypoglycemic effect of Hypoglycemic Agents. Selective Serotonin Reuptake Inhibitors may increase the serum concentration of Hypoglycemic Agents. Management: Consider increased monitoring of glycemic control with concomitant use of a hypoglycemic agent and an SSRI. Dosage adjustments of the hypoglycemic agent may be necessary upon SSRI initiation or discontinuation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Somatropin: May diminish the hypoglycemic effect of Antidiabetic Agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: May diminish the therapeutic effect of Antidiabetic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F2984567\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Use caution with chromium, garlic, gymnema (may increase hypoglycemia).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F2114352\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F2114353\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have been shown in some animal studies. Maternal hyperglycemia can be associated with adverse effects in the fetus, including macrosomia, neonatal hyperglycemia, and hyperbilirubinemia; the risk of congenital malformations is increased when Hb A",
"     <sub>",
"      1c",
"     </sub>",
"     is &gt;1% above the normal range.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Insulin requirements tend to fall during the first trimester of pregnancy and increase in the later trimesters, peaking at 28-32 weeks of gestation. Following delivery, insulin requirements decrease rapidly. Diabetes can also be associated with adverse effects in the mother. Poorly-treated diabetes may cause end-organ damage that may in turn negatively affect obstetric outcomes. Physiologic glucose levels should be maintained prior to and during pregnancy to decrease the risk of adverse events in the fetus and the mother. Insulin is the drug of choice for the control of diabetes mellitus during pregnancy. When compared to NPH insulin, insulin glargine has not been found to increase the risk of adverse events during pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F2984572\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Urine sugar and acetone, serum glucose, electrolytes, Hb A",
"     <sub>",
"      1c",
"     </sub>",
"     , lipid profile",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F2984573\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Glucose, fasting:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Newborns: 30-90 mg/dL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 70-110 mg/dL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Recommendations for glycemic control with type 1 diabetes:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hb A",
"     <sub>",
"      1c",
"     </sub>",
"     :",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &lt;6 years: &le;8.5% and &ge;7.5%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     6-12 years: &lt;8%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     13-19 years: &lt;7.5%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adults: &lt;7%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Plasma glucose*:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Preprandial:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     &lt;6 years: 90-130 mg/dL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     6-12 years: 90-180 mg/dL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     13 years to Adults: 90-130 mg/dL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Bedtime and overnight:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     &lt;6 years: 110-200 mg/dL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     6-12 years: 100-180 mg/dL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     13-19 years: 90-150 mg/dL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Peak postprandial** : Adults: &lt;180 mg/dL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     *Plasma glucose concentrations are generally 10% to 15% higher than those in whole blood",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     **Peak postprandial plasma glucose is measured 1-2 hours after a meal",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F2984569\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Insulin acts via specific membrane-bound receptors on target tissues to regulate metabolism of carbohydrate, protein, and fats. Insulin facilitates entry of glucose into muscle, adipose, and other tissues via hexose transporters, including GLUT4. Insulin stimulates the cellular uptake of amino acids and increases cellular permeability to several ions, including potassium, magnesium, and phosphate. By activating sodium-potassium ATPases, insulin promotes the intracellular movement of potassium.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Target organs for insulin include the liver, skeletal muscle, and adipose tissue. Within the liver, insulin stimulates hepatic glycogen synthesis through the activation of the enzymes hexokinase, phosphofructokinase, and glycogen synthase as well as the inhibition of glucose-6 phosphatase. Insulin promotes hepatic synthesis of fatty acids, which are released into the circulation as lipoproteins. Skeletal muscle effects of insulin include increased protein synthesis and increased glycogen synthesis. Within adipose tissue, insulin stimulates the processing of circulating lipoproteins to provide free fatty acids, facilitating triglyceride synthesis and storage by adipocytes. Insulin also directly inhibits the hydrolysis of triglycerides.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Normally secreted by the pancreas, insulin products are manufactured for pharmacologic use through recombinant DNA technology using either",
"     <i>",
"      E. coli",
"     </i>",
"     or",
"     <i>",
"      Saccharomyces cerevisiae",
"     </i>",
"     . Insulins are categorized based on promptness and duration of effect, including rapid-, short-, intermediate-, and long-acting insulins. Insulin glargine is a long-acting insulin formulation.",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F2984570\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: 3-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: 24 hours",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F2984571\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Slow; after injection it forms microprecipitates in the skin which allow small amounts to release over time",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Partially metabolized in the skin to form two active metabolites",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: No pronounced peak",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Urine",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F2984574\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?5/34/5669?source=see_link\">",
"      see \"Insulin glargine: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Do not take any new medication during therapy unless approved by healthcare provider. This medication is used to control diabetes; it is not a cure. It is imperative to follow other components of prescribed treatment (eg, diet and exercise regimen). Take exactly as directed. Do not change dose or discontinue unless advised by healthcare provider. If you experience hypoglycemic reaction, contact healthcare provider immediately. Always carry quick source of sugar with you. Monitor glucose levels as directed by healthcare provider. Report adverse side effects, including chest pain or palpitations; persistent fatigue, confusion, headache; skin rash or redness; numbness of mouth, lips, or tongue; muscle weakness or tremors; vision changes; respiratory difficulty; or nausea, vomiting, or flu-like symptoms.",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F14455410\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Division of daily insulin requirement (\"conventional therapy\"):",
"     </b>",
"     Generally, 50% to 75% of the daily insulin dose is given as an intermediate- or long-acting form (eg, insulin glargine) of insulin (in 1-2 daily injections). The remaining portion of the 24-hour insulin requirement is divided and administered as either regular insulin or a rapid-acting form of insulin at the same time before breakfast and dinner.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Division of daily insulin requirement (\"intensive therapy\"):",
"     </b>",
"     Basal insulin delivery with 1 or 2 doses of intermediate- or long-acting insulin (eg, insulin glargine) formulations superimposed with doses of rapid- or very rapid-acting insulin formulations 3 or more times daily.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Alemzadeh R, Berhe T, and Wyatt DT, \"Flexible Insulin Therapy With Glargine Insulin Improved Glycemic Control and Reduced Severe Hypoglycemia Among Preschool-Aged Children With Type 1 Diabetes Mellitus,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2005, 115(5):1320-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/50/17190/abstract-text/15867042/pubmed\" id=\"15867042\" target=\"_blank\">",
"        15867042",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12633 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-183.1.191.153-340D2F8564-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_50_17190=[""].join("\n");
var outline_f16_50_17190=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2114346\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2186124\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F991016\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F991017\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2104245\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2114347\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529656\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2110688\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2984568\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529652\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2114344\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2110686\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2984565\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2984566\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529653\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2114383\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2114382\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2984567\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2114352\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2114353\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2984572\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2984573\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2984569\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2984570\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2984571\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2984574\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14455410\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12633\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12633|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?33/30/34279?source=related_link\">",
"      Insulin glargine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?5/34/5669?source=related_link\">",
"      Insulin glargine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_50_17191="Binder syndrome";
var content_f16_50_17191=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F53807&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F53807&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 594px\">",
"   <div class=\"ttl\">",
"    Binder syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 574px; height: 540px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Patient with Binder syndrome with characteristic shortened nose and convex upper lip.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_50_17191=[""].join("\n");
var outline_f16_50_17191=null;
var title_f16_50_17192="Unipolar depression in adults: Treatment with lithium";
var content_f16_50_17192=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Unipolar depression in adults: Treatment with lithium",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/50/17192/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/50/17192/contributors\">",
"     Michael Gitlin, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/50/17192/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/50/17192/contributors\">",
"     Peter P Roy-Byrne, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/50/17192/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/50/17192/contributors\">",
"     David Solomon, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/50/17192/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 6, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H15952998\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    is mainly used to treat bipolar disorder, which is characterized by recurrent episodes of depression, mania, and hypomania. However, lithium is also used as an adjunctive medication in patients who have inadequately responded to an antidepressant for treatment of unipolar depression (ie, depression with no lifetime history of mania or hypomania) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/1\">",
"     1",
"    </a>",
"    ]. In addition, lithium is used as monotherapy to treat acute episodes of unipolar depression and as maintenance treatment to prevent recurrence of unipolar depressive episodes.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    was first used by psychiatrists in the mid-1800s [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/2\">",
"     2",
"    </a>",
"    ]. The first controlled trial of lithium for unipolar depression was in 1968.",
"   </p>",
"   <p>",
"    The use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    as adjunctive treatment and as monotherapy for acute episodes and maintenance treatment of unipolar depression is reviewed here. The use of lithium to treat bipolar disorder is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/8/38026?source=see_link&amp;anchor=H3#H3\">",
"     \"Bipolar disorder in adults: Pharmacotherapy for acute mania, mixed episodes, and hypomania\", section on 'General principles'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/9/27802?source=see_link&amp;anchor=H5#H5\">",
"     \"Bipolar disorder in adults: Maintenance treatment\", section on 'Lithium'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11208494\">",
"    <span class=\"h1\">",
"     ADJUNCTIVE TREATMENT WITH LITHIUM FOR ACUTE DEPRESSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    in patients with unipolar depression is to augment an antidepressant that does not adequately treat a depressive syndrome. Lithium or an alternative adjunctive agent is often necessary because remission with antidepressant monotherapy occurs in only 28 to 47 percent of patients, even with an optimal trial [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. It is commonly thought that augmentation is more effective for patients who initially have a partial response to antidepressant monotherapy, compared with patients who do not respond at all, but this is not established [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3473158985\">",
"    <span class=\"h2\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Results from many studies support using",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    for patients who do not fully respond to an antidepressant [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A review of 27 open and controlled studies (803 depressed patients, &gt;90 percent unipolar) estimated that 50 percent of patients responded within two to six weeks of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      augmentation [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/9,10\">",
"       9,10",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A meta-analysis of two controlled trials (50 patients with unipolar depression) examined the efficacy of adding",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      to either a tricyclic or monoamine oxidase inhibitor antidepressant after the antidepressant had failed to adequately treat the depressive syndrome. Response (50 percent or more decrease in the depression rating scale score) occurred in significantly more patients who received lithium augmentation compared with patients who received placebo (42 versus 17 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A subsequent meta-analysis of 10 controlled trials (269 depressed patients: 194 unipolar, 14 bipolar, and 61 polarity not reported) also found significantly more patients responded to adjunctive",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      compared with placebo (41 versus 14 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/7\">",
"       7",
"      </a>",
"      ]. The results indicated that treatment of approximately five patients with adjunctive lithium provided a beneficial response in one additional patient that would not have occurred with placebo (number needed to treat of five).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most studies have examined",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    augmentation of tricyclic antidepressants. Thus, it is not clear whether lithium is efficacious as an adjunctive treatment with the other classes of antidepressants that are more widely used. Consistent with this concern, a controlled trial involving 100 patients with major depression (95 unipolar, 5 bipolar) found response (50 percent or more decrease in the depression rating scale score) occurred in significantly more patients who received lithium augmentation of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/41/41624?source=see_link\">",
"     imipramine",
"    </a>",
"    compared with lithium augmentation of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/41/32408?source=see_link\">",
"     mirtazapine",
"    </a>",
"    (64 versus 48 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/12\">",
"     12",
"    </a>",
"    ]. Another study found adjunctive lithium was minimally effective in 69 patients with unipolar major depression who failed two trials of antidepressant medication and subsequently received a third trial with lithium augmentation of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     citalopram",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     sertraline",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/29/26073?source=see_link\">",
"     bupropion",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/45/22233?source=see_link\">",
"     venlafaxine",
"    </a>",
"    : only 16 percent remitted [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are no established predictors of response to adjunctive",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    in patients with unipolar depression. Failure of monotherapy with multiple antidepressants may be associated with poorer outcomes for lithium augmentation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. In addition, augmentation may be more effective in patients who partially respond to antidepressant monotherapy (eg, a 25 to 49 percent decrease in the depression rating scale score), compared with patients who show no response (eg, a decrease less than 25 percent in the depression rating scale score) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    augmentation may reduce risk of completed in patients with unipolar depression. (See",
"    <a class=\"local\" href=\"#H11208578\">",
"     'Reduced risk of suicide'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2757307\">",
"    <span class=\"h3\">",
"     Compared with other drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Only a few controlled trials have compared the efficacy of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    with other drugs for augmenting an antidepressant that has inadequately treated a depressive syndrome. The limited data suggest that lithium is comparable to T3 (triiodothyronine) or a second antidepressant.",
"   </p>",
"   <p>",
"    Other medications are used more often than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    as augmentation, despite the robust evidence supporting adjunctive lithium. A study examined a pharmacy data base that included nearly 250,000 patients with unipolar depression, and found that more patients received a second antidepressant, an antipsychotic, or an anticonvulsant as augmentation compared with lithium (10.9 versus 7.3 versus 3.7 versus 0.5 percent of all patients) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/15\">",
"     15",
"    </a>",
"    ]. This may reflect the perception that lithium often causes side effects and long-term toxicity. In addition, clinicians must monitor serum lithium levels, renal function tests, and thyroid function tests. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/14/32999?source=see_link\">",
"     \"Renal toxicity of lithium\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/29/42453?source=see_link\">",
"     \"Lithium and the thyroid\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Use of second-generation antipsychotics as add-on therapy to treat unipolar, nonpsychotic major depression that is unresponsive to an antidepressant is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/15/31993?source=see_link\">",
"     \"Unipolar depression in adults: Treatment with second-generation antipsychotics\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2757334\">",
"    <span class=\"h4\">",
"     Triiodothyronine (T3)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two randomized trials found that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    was comparable to triiodothyronine (T3) for augmenting a tricyclic antidepressant,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     citalopram",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     sertraline",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/29/26073?source=see_link\">",
"     bupropion",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/45/22233?source=see_link\">",
"     venlafaxine",
"    </a>",
"    in patients with unipolar major depression [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/13,16\">",
"     13,16",
"    </a>",
"    ]. One trial compared lithium, T3, and placebo in 50 patients who did not respond to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/14/39144?source=see_link\">",
"     desipramine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/41/41624?source=see_link\">",
"     imipramine",
"    </a>",
"    , and found that response (improvement from baseline on the depression rating scale &ge; 50 percent) occurred in significantly more patients who received adjunctive lithium or T3, compared with placebo (53 and 59 versus 19 percent); there was no significant difference between lithium and T3 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/16\">",
"     16",
"    </a>",
"    ]. The second trial was open label and compared lithium with T3 in 73 patients who prospectively failed antidepressant monotherapy; there was no significant difference in the proportion of patients who remitted with either adjunctive lithium or T3 (16 versus 25 percent), nor in time to remission [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/13\">",
"     13",
"    </a>",
"    ]. However, withdrawal from treatment because of side effects was significantly greater for patients who received lithium compared with patients who received T3",
"    <sub>",
"    </sub>",
"    (23 versus 10 percent).",
"   </p>",
"   <p>",
"    Use of T3 as add-on therapy to treat unipolar, nonpsychotic major depression that is unresponsive to an antidepressant is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/34/27175?source=see_link\">",
"     \"Unipolar depression in adults: Augmentation of antidepressants with thyroid hormone\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2757341\">",
"    <span class=\"h4\">",
"     Antidepressants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two randomized trials found that low-dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    (300 to 600 mg per day) was comparable to low-dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/14/39144?source=see_link\">",
"     desipramine",
"    </a>",
"    (25 to 50 mg per day) as augmentation in patients with unipolar major depression [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. In each trial, patients who had a partial response or no response to eight weeks of treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    (20 mg per day) were assigned to lithium plus fluoxetine or desipramine plus fluoxetine for four weeks. The proportion of patients who remitted in the two trials was similar in the groups who received lithium augmentation compared with the groups who received desipramine augmentation (29 and 24 versus 25 and 29 percent). Trials comparing therapeutic doses of these medications have not been conducted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11208500\">",
"    <span class=\"h2\">",
"     Dose",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest clinicians initially prescribe adjunctive",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    300 mg per day, or 300 mg twice per day. The dose should be increased every one or two days depending on how well it is tolerated, to an eventual target dose of 900 mg per day, or a dose sufficient to achieve 12-hour serum levels of 0.6 to 0.9",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    (0.6 to 0.9",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One study compared",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    750 mg per day versus 250 mg per day as adjunctive treatment in 34 patients with unipolar major depression who did not respond to treatment with a tricyclic antidepressant [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/20\">",
"     20",
"    </a>",
"    ]. Significantly more patients responded (50 percent or more decrease in the depression rating scale score) with 750 mg per day (44 versus 18 percent).",
"   </p>",
"   <p>",
"    A meta-analysis of nine controlled trials (234 patients) found no evidence for a dose response relationship beyond 800 mg daily [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/21\">",
"     21",
"    </a>",
"    ]. A second meta-analysis of 10 controlled trials (269 patients) found that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    augmentation was significantly more efficacious compared with placebo, with lithium generally prescribed at a dose of 900",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/7\">",
"     7",
"    </a>",
"    ]. Serum levels generally ranged from 0.6 to 1.0",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    (0.6 to 1.0",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    In a subsequent controlled trial, adjunctive lithium was started at 225 mg or 450 mg per day for one week, and titrated up to a target dose of 900 mg per day; the final mean daily dose was 860 mg and the median serum level was 0.6",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    (0.6",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11208506\">",
"    <span class=\"h2\">",
"     Duration",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest clinicians prescribe adjunctive",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    for at least four weeks before deciding whether it is helpful [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/19\">",
"     19",
"    </a>",
"    ]. Remission may be seen as soon as one week. In one trial, patients with unipolar major depression were treated with adjunctive lithium for up to 14 weeks and a mean of nine weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/13\">",
"     13",
"    </a>",
"    ]. Among the nine patients who eventually remitted:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      two remitted after 2 weeks of treatment",
"     </li>",
"     <li>",
"      three after 3 to 4 weeks",
"     </li>",
"     <li>",
"      one after 5 to 6 weeks",
"     </li>",
"     <li>",
"      one after 7 to 12 weeks",
"     </li>",
"     <li>",
"      two after 13 to 14 weeks",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Another study found that depression rating scale scores began to decline in week one of treatment with adjunctive",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    and steadily decreased during six weeks of treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients who respond to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    augmentation should be maintained on the lithium-antidepressant combination for at least one year [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/9,22\">",
"     9,22",
"    </a>",
"    ]. The largest controlled trial that examined this issue studied 29 patients with unipolar major depression who initially did not respond to antidepressant monotherapy (primarily tricyclics), but subsequently remitted with adjunctive lithium [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/23\">",
"     23",
"    </a>",
"    ]. All patients then continued their antidepressant, and were randomly assigned to continue adjunctive lithium or to receive placebo for four months. Relapse occurred in significantly fewer patients who received lithium compared with placebo (0 versus 46 percent). Afterwards, the 14 patients who had received lithium plus an antidepressant were tapered off all their medication, which led to recurrence of depression in five patients during six months of follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/24\">",
"     24",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2519580192\">",
"    <span class=\"h2\">",
"     Contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    is contraindicated in patients with:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Significant renal impairment",
"     </li>",
"     <li>",
"      Sodium depletion",
"     </li>",
"     <li>",
"      Dehydration",
"     </li>",
"     <li>",
"      Significant cardiovascular disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Contraindications and precautions are discussed in greater detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/8/38026?source=see_link&amp;anchor=H1829248939#H1829248939\">",
"     \"Bipolar disorder in adults: Pharmacotherapy for acute mania, mixed episodes, and hypomania\", section on 'Lithium'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2519580450\">",
"    <span class=\"h2\">",
"     Drug interactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    interacts with many drugs. Medications that decrease renal lithium excretion and are particularly prone to increase serum levels with possible toxicity are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Thiazide diuretics",
"     </li>",
"     <li>",
"      Nonsteroidal anti-inflammatory drugs (NSAID)",
"     </li>",
"     <li>",
"      Angiotensin converting enzyme (ACE) inhibitors",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Drug interactions with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    are discussed in greater depth elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/8/38026?source=see_link&amp;anchor=H1829248939#H1829248939\">",
"     \"Bipolar disorder in adults: Pharmacotherapy for acute mania, mixed episodes, and hypomania\", section on 'Lithium'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2519581674\">",
"    <span class=\"h2\">",
"     Laboratory monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians must monitor serum",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    levels, renal function tests, and thyroid function tests. Laboratory monitoring is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/8/38026?source=see_link&amp;anchor=H1829248939#H1829248939\">",
"     \"Bipolar disorder in adults: Pharmacotherapy for acute mania, mixed episodes, and hypomania\", section on 'Lithium'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11208518\">",
"    <span class=\"h2\">",
"     Side effects with lithium augmentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    and an antidepressant is often well tolerated. Although most controlled studies have examined lithium augmentation of tricyclic antidepressants, there is more information available about side effects that occur during lithium augmentation of a selective serotonin reuptake inhibitor.",
"   </p>",
"   <p>",
"    Acute side effects of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    augmentation are reviewed here. Side effects of lithium monotherapy and longer-term toxicity are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/8/38026?source=see_link&amp;anchor=H1829248939#H1829248939\">",
"     \"Bipolar disorder in adults: Pharmacotherapy for acute mania, mixed episodes, and hypomania\", section on 'Lithium'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/14/32999?source=see_link\">",
"     \"Renal toxicity of lithium\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/29/42453?source=see_link\">",
"     \"Lithium and the thyroid\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11208524\">",
"    <span class=\"h3\">",
"     Selective serotonin reuptake inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;An observational study compared 110 patients receiving",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    monotherapy with a matched group of 110 patients receiving fluoxetine plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    and found no significant differences in the number and type of adverse events during seven weeks of treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/25\">",
"     25",
"    </a>",
"    ]. In addition, a review of reports with a total of 503 patients, who were treated with lithium plus a selective serotonin reuptake inhibitor, found none of the patients suffered a serious or life-threatening adverse event [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/26\">",
"     26",
"    </a>",
"    ]. The side effects that occur most frequently during lithium augmentation of a selective serotonin reuptake inhibitor are [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/17,25,26\">",
"     17,25,26",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Gastrointestinal distress (nausea, diarrhea)",
"     </li>",
"     <li>",
"      Sedation",
"     </li>",
"     <li>",
"      Tremor",
"     </li>",
"     <li>",
"      Anxiety and nervousness",
"     </li>",
"     <li>",
"      Insomnia",
"     </li>",
"     <li>",
"      Headache",
"     </li>",
"     <li>",
"      Dry mouth",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11208530\">",
"    <span class=\"h3\">",
"     Tricyclic and tetracyclic drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;The side effects that occur most frequently during",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    augmentation of a cyclic antidepressant are [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/27\">",
"     27",
"    </a>",
"    ]",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Nausea",
"     </li>",
"     <li>",
"      Tremor",
"     </li>",
"     <li>",
"      Polyuria",
"     </li>",
"     <li>",
"      Dry mouth",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11208536\">",
"    <span class=\"h2\">",
"     Mechanism of action",
"    </span>",
"    &nbsp;&mdash;&nbsp;The benefit of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    augmentation for treating unipolar major depression may be due to synergy between lithium and the antidepressant, or to the antidepressant effect of lithium itself [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/8\">",
"     8",
"    </a>",
"    ]. In either case, the mechanism of action is unclear. Most hypotheses suggest lithium enhances serotonergic function [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/22\">",
"     22",
"    </a>",
"    ]. Pharmacogenetic studies suggest that several single nucleotide polymorphisms are involved [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11208566\">",
"    <span class=\"h1\">",
"     LITHIUM MONOTHERAPY FOR ACUTE DEPRESSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    monotherapy may effectively treat acute unipolar depression, but there is far less evidence than there is for antidepressants [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. We do not use lithium as first-, second-, or third-line treatment for acute unipolar depression.",
"   </p>",
"   <p>",
"    A six-week controlled trial assigned 27 patients with major depression to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    or placebo. Fewer patients who received lithium withdrew from the study as treatment failures, and among patients who remained in the study, depression rating scale scores were significantly lower at weeks four and five in patients who received lithium compared with patients who received placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A meta-analysis of four controlled studies, in which 148 patients were treated for three weeks with either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    at a serum level of 0.4 to 1.5",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    (0.4 to 1.5",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    or with an antidepressant, found a moderate clinical effect favoring lithium [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/29\">",
"     29",
"    </a>",
"    ]. A subsequent controlled study that compared lithium with the tricyclic",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"     clomipramine",
"    </a>",
"    found that they had comparable efficacy in treating unipolar depression [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/30\">",
"     30",
"    </a>",
"    ]. The lack of a placebo arm makes it more difficult to interpret the treatment effects observed in these studies. In addition, no study has compared lithium with selective serotonin reuptake inhibitors (SSRIs),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/45/22233?source=see_link\">",
"     venlafaxine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/33/18967?source=see_link\">",
"     desvenlafaxine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/62/37864?source=see_link\">",
"     duloxetine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/41/32408?source=see_link\">",
"     mirtazapine",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/29/26073?source=see_link\">",
"     bupropion",
"    </a>",
"    for treating acute unipolar depression.",
"   </p>",
"   <p>",
"    When",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    is used to treat acute depression, we suggest it be prescribed to achieve a serum level of 0.6 to 1.2",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    (0.6 to 1.2",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    based upon our clinical experience. There are no established predictors for lithium&rsquo;s acute antidepressant effect. Lithium may be more effective for bipolar depression compared with unipolar depression, thus, a family history of bipolar depression may possibly predict a better outcome for lithium&rsquo;s efficacy in acute unipolar depression [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/31,32\">",
"     31,32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11208572\">",
"    <span class=\"h1\">",
"     LITHIUM MONOTHERAPY AS MAINTENANCE TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    prevents recurrence of unipolar depression.",
"   </p>",
"   <p>",
"    Two meta-analyses have compared the efficacy of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    monotherapy with placebo as maintenance treatment. One meta-analysis of eight controlled trials (263 patients with unipolar depression) found that recurrence of depression occurred in significantly fewer patients who received lithium compared with patients who received placebo (34 versus 67 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/29\">",
"     29",
"    </a>",
"    ]. A subsequent meta-analysis of a nine controlled trials (229 patients with unipolar depression) found that recurrence of depression occurred in significantly fewer patients who received lithium compared with patients who received placebo (36 versus 75 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two meta-analyses have compared the efficacy of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    monotherapy with an antidepressant as maintenance treatment. One meta-analysis of seven controlled trials (298 patients with unipolar depression) found that recurrence of depression occurred in a similar number of patients who received lithium compared with patients who received a tricyclic antidepressant (48 versus 56 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/29\">",
"     29",
"    </a>",
"    ]. A subsequent meta-analysis of eight trials (475 patients, the large majority had unipolar depression) also compared the efficacy of lithium with antidepressants in preventing recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/34\">",
"     34",
"    </a>",
"    ]. One analysis that defined recurrence as admission to the hospital (three studies with 152 patients) found recurrence of depression occurred in significantly fewer patients who received lithium compared with patients who received an antidepressant (7 versus 22 percent). Analyses that used different definitions of recurrence found that the rate of recurrence was comparable for patients who received lithium and patients who received an antidepressant. In addition, there were no significant differences between lithium and antidepressants in the overall drop-out rate (as a proxy measure of overall acceptability of treatment), drop-out due to side effects, and number of patients who reported at least one side-effect. The lack of a placebo arm makes it more difficult to interpret the treatment effects observed in these studies.",
"   </p>",
"   <p>",
"    Another meta-analysis examined the benefits of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    prophylaxis in mirror-image studies [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/33\">",
"     33",
"    </a>",
"    ]. In these case-controlled studies, the rate of depressive recurrences during a specified time period prior to using maintenance lithium (eg, two years) was compared with the rate of recurrence for the same length of time after lithium maintenance treatment was introduced into the patient&rsquo;s treatment regimen. The analysis found that the number of recurrences before lithium decreased by 69 percent after lithium. Results from mirror-image studies need to be interpreted cautiously, because they assume everything, except the intervention, has remained the same during the two time periods that are compared. This assumption is problematic.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    is not used often to prevent recurrence of unipolar depression in the United States, despite the evidence supporting it. As an example, the American Psychiatric Association Practice Guidelines for Major Depressive Disorder do not mention lithium as an option for maintenance treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/35\">",
"     35",
"    </a>",
"    ]. However, based upon our clinical experience, we consider using lithium monotherapy as maintenance treatment for patients who fail maintenance treatment with an antidepressant. In addition, patients who respond to lithium augmentation for treatment of an acute depressive syndrome are also candidates for lithium monotherapy maintenance treatment. Lithium may also be useful in maintenance treatment as augmentation of an antidepressant, but there is little evidence to support this practice.",
"   </p>",
"   <p>",
"    Based upon the serum levels used in controlled trials and our clinical experience, we suggest clinicians prescribe",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    to achieve a serum level of 0.6 to 1.2",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    (0.6 to 1.2",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    There are no established factors that predict response to maintenance treatment with lithium monotherapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11208578\">",
"    <span class=\"h1\">",
"     REDUCED RISK OF SUICIDE",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    is the only psychotropic agent that appears to reduce the risk of suicide in patients with mood disorders, including recurrent unipolar major depression [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/36-39\">",
"     36-39",
"    </a>",
"    ]. One review pooled results from eight studies (329 patients with unipolar major depression, most of whom received antidepressants and other medications) and found that the risk of completed suicide was 85 percent lower in patients who received lithium compared with patients who did not [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a subsequent controlled trial, 167 patients with unipolar depression, who had attempted suicide, were randomly assigned to receive",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    or placebo for one year as add-on therapy to their ongoing pharmacotherapy and psychotherapy. Post hoc analysis showed that completed suicide occurred in significantly fewer patients who received lithium compared with patients who received placebo (zero versus three patients) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17192/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We consider using",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    to reduce the risk of suicide in patients who demonstrate repeated or chronic suicidality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11208584\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"       Lithium",
"      </a>",
"      is efficacious as augmentation for an antidepressant that does not adequately treat a depressive syndrome. Clinicians should initially prescribe adjunctive lithium 300 mg per day, or 300 mg twice per day. The dose should be increased every one or two days depending on how well it is tolerated, to an eventual target dose of 900 mg per day, or a dose to achieve 12-hour serum levels of 0.6 to 0.9",
"      <span class=\"nowrap\">",
"       mEq/L",
"      </span>",
"      (0.6 to 0.9",
"      <span class=\"nowrap\">",
"       mmol/L).",
"      </span>",
"      &nbsp;(See",
"      <a class=\"local\" href=\"#H11208494\">",
"       'Adjunctive treatment with lithium for acute depression'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Only a few controlled trials have compared the efficacy of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      with other drugs for augmenting an antidepressant that has inadequately treated a depressive syndrome, but the limited data suggest that lithium is comparable to T",
"      <sub>",
"       3",
"      </sub>",
"      (triiodothyronine) or a second antidepressant. (See",
"      <a class=\"local\" href=\"#H2757307\">",
"       'Compared with other drugs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"       Lithium",
"      </a>",
"      monotherapy may effectively treat acute unipolar depression, but the evidence is limited. (See",
"      <a class=\"local\" href=\"#H11208566\">",
"       'Lithium monotherapy for acute depression'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"       Lithium",
"      </a>",
"      monotherapy prevents recurrent episodes of unipolar depression. Lithium maintenance treatment generally requires a serum level of 0.6 to 1.2",
"      <span class=\"nowrap\">",
"       mEq/L",
"      </span>",
"      (0.6 to 1.2",
"      <span class=\"nowrap\">",
"       mmol/L).",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H11208572\">",
"       'Lithium monotherapy as maintenance treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"       Lithium",
"      </a>",
"      may reduce the risk of suicide in patients with recurrent unipolar major depression. (See",
"      <a class=\"local\" href=\"#H11208578\">",
"       'Reduced risk of suicide'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/1\">",
"      D&eacute; Montigny C, Grunberg F, Mayer A, Deschenes JP. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. Br J Psychiatry 1981; 138:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/2\">",
"      Shorter E. The history of lithium therapy. Bipolar Disord 2009; 11 Suppl 2:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/3\">",
"      Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006; 163:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/4\">",
"      Thase ME, Haight BR, Richard N, et al. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. J Clin Psychiatry 2005; 66:974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/5\">",
"      Thase ME, Nierenberg AA, Vrijland P, et al. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression. Int Clin Psychopharmacol 2010; 25:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/6\">",
"      Hirschfeld RM, Montgomery SA, Aguglia E, et al. Partial response and nonresponse to antidepressant therapy: current approaches and treatment options. J Clin Psychiatry 2002; 63:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/7\">",
"      Crossley NA, Bauer M. Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials. J Clin Psychiatry 2007; 68:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/8\">",
"      Bauer M, Adli M, Bschor T, et al. Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants. Neuropsychobiology 2010; 62:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/9\">",
"      Bauer M, Forsthoff A, Baethge C, et al. Lithium augmentation therapy in refractory depression-update 2002. Eur Arch Psychiatry Clin Neurosci 2003; 253:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/10\">",
"      Bauer M, Adli M, Baethge C, et al. Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms. Can J Psychiatry 2003; 48:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/11\">",
"      Stimpson N, Agrawal N, Lewis G. Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression. Systematic review. Br J Psychiatry 2002; 181:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/12\">",
"      Bruijn JA, Moleman P, Mulder PG, van den Broek WW. Comparison of 2 treatment strategies for depressed inpatients: imipramine and lithium addition or mirtazapine and lithium addition. J Clin Psychiatry 1998; 59:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/13\">",
"      Nierenberg AA, Fava M, Trivedi MH, et al. A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry 2006; 163:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/14\">",
"      Jayaraman A, Nandhra H. Systematic review of lithium augmentation in depression resistant to at least 2 antidepressants. Prim Care Companion J Clin Psychiatry 2009; 11:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/15\">",
"      Valenstein M, McCarthy JF, Austin KL, et al. What happened to lithium? Antidepressant augmentation in clinical settings. Am J Psychiatry 2006; 163:1219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/16\">",
"      Joffe RT, Singer W, Levitt AJ, MacDonald C. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiatry 1993; 50:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/17\">",
"      Fava M, Alpert J, Nierenberg A, et al. Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine. J Clin Psychopharmacol 2002; 22:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/18\">",
"      Fava M, Rosenbaum JF, McGrath PJ, et al. Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study. Am J Psychiatry 1994; 151:1372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/19\">",
"      Lam RW, Kennedy SH, Grigoriadis S, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. J Affect Disord 2009; 117 Suppl 1:S26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/20\">",
"      Stein G, Bernadt M. Lithium augmentation therapy in tricyclic-resistant depression. A controlled trial using lithium in low and normal doses. Br J Psychiatry 1993; 162:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/21\">",
"      Bauer M, Dopfmer S. Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies. J Clin Psychopharmacol 1999; 19:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/22\">",
"      Bschor T, Bauer M. Efficacy and mechanisms of action of lithium augmentation in refractory major depression. Curr Pharm Des 2006; 12:2985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/23\">",
"      Bauer M, Bschor T, Kunz D, et al. Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression. Am J Psychiatry 2000; 157:1429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/24\">",
"      Bschor T, Bergh&ouml;fer A, Str&ouml;hle A, et al. How long should the lithium augmentation strategy be maintained? A 1-year follow-up of a placebo-controlled study in unipolar refractory major depression. J Clin Psychopharmacol 2002; 22:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/25\">",
"      Bauer M, Linden M, Schaaf B, Weber HJ. Adverse events and tolerability of the combination of fluoxetine/lithium compared with fluoxetine. J Clin Psychopharmacol 1996; 16:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/26\">",
"      Hawley CJ, Loughlin PJ, Quick SJ, et al. Efficacy, safety and tolerability of combined administration of lithium and selective serotonin reuptake inhibitors: a review of the current evidence. Hertfordshire Neuroscience Research Group. Int Clin Psychopharmacol 2000; 15:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/27\">",
"      Zusky PM, Biederman J, Rosenbaum JF, et al. Adjunct low dose lithium carbonate in treatment-resistant depression: a placebo-controlled study. J Clin Psychopharmacol 1988; 8:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/28\">",
"      Khan MC, Wickham EA, Reed JV. Lithium versus placebo in acute depression: a clinical trial. Int Clin Psychopharmacol 1987; 2:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/29\">",
"      Souza FG, Goodwin GM. Lithium treatment and prophylaxis in unipolar depression: a meta-analysis. Br J Psychiatry 1991; 158:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/30\">",
"      Linder J, Fyr&ouml; B, Pettersson U, Werner S. Acute antidepressant effect of lithium is associated with fluctuation of calcium and magnesium in plasma. A double-blind study on the antidepressant effect of lithium and clomipramine. Acta Psychiatr Scand 1989; 80:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/31\">",
"      Mendels J, Ramsey TA, Dyson WL, Frazer A. Lithium as an antidepressant. Arch Gen Psychiatry 1979; 36:845.",
"     </a>",
"    </li>",
"    <li>",
"     Bauer, M, Crossley, NA, Gerber, S, et al. The acute antidepressive effects of lithium: from monotherapy to augmentation therapy in major depression. In: Lithium in Neuropsychiatry, Bauer, et al (Eds), Informa UK Ltd, United Kingdom 2006. p.109.",
"    </li>",
"    <li>",
"     Davis, JM. Lithium maintenance of unipolar depression. In: Lithium in Neuropsychiatry: The Comprehensive Guide, Bauer, M, Grof, P, Muller-Oerlinghausen, B (Eds), Informa UK Ltd, 2006. p.99.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/34\">",
"      Cipriani A, Smith K, Burgess S, et al. Lithium versus antidepressants in the long-term treatment of unipolar affective disorder. Cochrane Database Syst Rev 2006; :CD003492.",
"     </a>",
"    </li>",
"    <li>",
"     American Psychiatric Association. Practice guidelines for the treatment of patients with major depressive disorder, 2nd, American Psychiatric Press, 2000",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/36\">",
"      Cipriani A, Pretty H, Hawton K, Geddes JR. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 2005; 162:1805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/37\">",
"      Guzzetta F, Tondo L, Centorrino F, Baldessarini RJ. Lithium treatment reduces suicide risk in recurrent major depressive disorder. J Clin Psychiatry 2007; 68:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/38\">",
"      Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord 2002; 68:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/39\">",
"      Coppen A. Lithium in unipolar depression and the prevention of suicide. J Clin Psychiatry 2000; 61 Suppl 9:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17192/abstract/40\">",
"      Lauterbach E, Felber W, M&uuml;ller-Oerlinghausen B, et al. Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial. Acta Psychiatr Scand 2008; 118:469.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13506 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-110.137.129.113-C8DC72A068-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_50_17192=[""].join("\n");
var outline_f16_50_17192=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11208584\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15952998\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11208494\">",
"      ADJUNCTIVE TREATMENT WITH LITHIUM FOR ACUTE DEPRESSION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3473158985\">",
"      Efficacy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2757307\">",
"      - Compared with other drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H2757334\">",
"      Triiodothyronine (T3)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H2757341\">",
"      Antidepressants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11208500\">",
"      Dose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11208506\">",
"      Duration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2519580192\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2519580450\">",
"      Drug interactions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2519581674\">",
"      Laboratory monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11208518\">",
"      Side effects with lithium augmentation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11208524\">",
"      - Selective serotonin reuptake inhibitors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11208530\">",
"      - Tricyclic and tetracyclic drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11208536\">",
"      Mechanism of action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11208566\">",
"      LITHIUM MONOTHERAPY FOR ACUTE DEPRESSION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11208572\">",
"      LITHIUM MONOTHERAPY AS MAINTENANCE TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11208578\">",
"      REDUCED RISK OF SUICIDE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11208584\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/9/27802?source=related_link\">",
"      Bipolar disorder in adults: Maintenance treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/8/38026?source=related_link\">",
"      Bipolar disorder in adults: Pharmacotherapy for acute mania, mixed episodes, and hypomania",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/29/42453?source=related_link\">",
"      Lithium and the thyroid",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/14/32999?source=related_link\">",
"      Renal toxicity of lithium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/34/27175?source=related_link\">",
"      Unipolar depression in adults: Augmentation of antidepressants with thyroid hormone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/15/31993?source=related_link\">",
"      Unipolar depression in adults: Treatment with second-generation antipsychotics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_50_17193="RML and RLL atelectasis I";
var content_f16_50_17193=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F52547%7EPULM%2F65349&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F52547%7EPULM%2F65349&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Combined right middle and right lower lobe atelectasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 338px; height: 350px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Upright chest radiograph showing atelectasis in the right middle and lower lobes after cholecystectomy. The prominent findings include elevation of the right lung base (arrow) with obscuring of the right hilar structures, basilar pulmonary vessels, and right heart border. This radiograph was initially interpreted as a subpulmonic effusion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Reversal of right middle and lower lobe atelectasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 374px; height: 376px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Upright chest radiograph from the previous patient with right middle and lower lobe atelectasis taken the next day after chest physiotherapy. The right middle and lower lobes are now partially aerated and the right heart border and the right hemidiaphragm are faintly visible.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_50_17193=[""].join("\n");
var outline_f16_50_17193=null;
var title_f16_50_17194="Physiologic changes following lung transplantation";
var content_f16_50_17194=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Physiologic changes following lung transplantation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/50/17194/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/50/17194/contributors\">",
"     Roland G Nador, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/50/17194/contributors\">",
"     Lianne G Singer, MD, FRCPC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/50/17194/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/50/17194/contributors\">",
"     Elbert P Trulock, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/50/17194/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/50/17194/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/50/17194/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Important physiologic changes occur over the months to years following lung transplantation. Some changes affect all lung transplant recipients; others may be dependent upon the type of lung transplant surgery performed (single lung transplantation (SLT), bilateral sequential or double lung transplantation (BLT), heart-lung transplantation (HLT), and living donor lobar transplantation (LDLT)), or on the pre-transplant diagnosis (eg, COPD, interstitial lung disease, cystic fibrosis, pulmonary hypertension).",
"   </p>",
"   <p>",
"    The effect of lung transplantation on long-term general respiratory physiology will be presented here. Other outcome measures, such as survival and quality of life, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/25/3480?source=see_link\">",
"     \"Lung transplantation: An overview\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/6/99?source=see_link\">",
"     \"Heart-lung transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ANATOMIC CHANGES",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the process of harvesting a lung for transplantation, the vagus and sympathetic nerves, pulmonary and bronchial blood vessels, and lymphatics are interrupted. Although the pulmonary artery and pulmonary veins are reanastomosed to those of the recipient, the bronchial arteries that supply the airways are usually not revascularized. The recipient phrenic, vagus, and recurrent laryngeal nerves are sometimes injured during the operative procedure, more commonly during heart-lung transplantation or when cardiopulmonary bypass is needed.",
"   </p>",
"   <p>",
"    Postoperative respiratory function of the recipient will reflect these changes in addition to any lung injury that occurs related to the procedure. If a single lung is transplanted, postoperative function will reflect the combination of donor lung and diseased recipient lung. A discussion of the different surgical procedures is provided separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/50/38697?source=see_link\">",
"     \"Lung transplantation: Procedure and postoperative management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     GENERAL PHYSIOLOGIC CHANGES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lung transplantation alters many components of respiratory physiology. Some changes result from the surgical procedure, such as denervation of the transplanted lung, interrupted cough reflex, and reduced gastroesophageal motility.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Airway reactivity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mild airway hyperresponsiveness, particularly in response to certain bronchoprovocations, is common among lung and heart-lung transplant recipients. However, it is generally not a clinically significant problem. Nevertheless, this abnormality may be associated with an increased risk of developing bronchiolitis obliterans syndrome (BOS).",
"   </p>",
"   <p>",
"    Bronchial hyperresponsiveness in response to exercise, isocapnic hyperventilation, and inhalation of histamine and distilled water has been studied in lung transplant recipients. Small studies have found that neither exercise nor isocapnic hyperventilation provokes a significant decrement in forced expiratory volume in one second (FEV",
"    <sub>",
"     1",
"    </sub>",
"    ); distilled water inhalation challenge stimulated only a modest response in a minority of HLT recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/32/10756?source=see_link\">",
"     Methacholine",
"    </a>",
"    challenge tests have yielded conflicting results. Hyperresponsiveness to methacholine has been confirmed in some, but not all studies [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. When present, hyperresponsiveness was attributed to denervation hypersensitivity of airway smooth muscle muscarinic receptors [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. Response to methacholine does not appear to correlate with time since transplantation, post-transplantation FEV",
"    <sub>",
"     1",
"    </sub>",
"    , acute rejection, or airway inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/3,6\">",
"     3,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although bronchial hyperreactivity is nonspecific, early bronchial hyperresponsiveness to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/32/10756?source=see_link\">",
"     methacholine",
"    </a>",
"    has been associated with a higher likelihood of developing BOS [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/25/18841?source=see_link\">",
"     \"Chronic lung transplant rejection: Bronchiolitis obliterans\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Cough reflex and mucociliary clearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two important lung defenses, the cough reflex and mucociliary clearance, are impaired following transplantation. These changes probably influence susceptibility to respiratory infection and the consequences of aspiration.",
"   </p>",
"   <p>",
"    The afferent limb of the cough reflex from the transplanted lung is interrupted during harvesting. Coughing can be stimulated from a remaining native lung or from sites in the respiratory tract proximal to the airway anastomosis. HLT recipients show a markedly decreased response to inhalation of nebulized distilled water despite the preservation of the laryngeal cough response [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Reduced airway clearance may be a risk factor for sequelae of aspiration (eg, lung injury and infection) in that prolonged contact time leads to greater likelihood of lung or airway injury. This problem has been demonstrated by the presence of bile acids in the BAL of some transplant recipients, which appeared to be a risk factor for bronchiolitis obliterans syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mucociliary clearance appears to be modestly decreased in the transplanted lung, but the mechanism has not been fully elucidated. Mucociliary transport depends upon the interaction between cilia and the overlying layer of mucus [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/12\">",
"     12",
"    </a>",
"    ]. Both epithelial damage and ciliary dysfunction may contribute to poor clearance [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/13,14\">",
"     13,14",
"    </a>",
"    ], but mucus secretion is also influenced by neurologic control. It is possible that post-transplant alterations in the quantity or the composition of mucus change its rheologic properties and retard clearance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Control of breathing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Control of breathing is subtly altered after heart-lung and lung transplantation, but the changes are not clinically significant. The ventilatory response to hypercapnia has been variable [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/15-20\">",
"     15-20",
"    </a>",
"    ]. In one series of patients with obstructive lung disease, hypercapnia, and a blunted response to CO",
"    <sub>",
"     2",
"    </sub>",
"    rebreathing before transplantation, hypercapnia and decreased ventilatory response to CO",
"    <sub>",
"     2",
"    </sub>",
"    persisted during the first week after SLT or BLT, but resolved by three weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Both normal and mildly blunted responses to hypercapnia have been reported later in the postoperative period [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]; however, the ventilatory response to isocapnic hypoxia remains normal [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/4/40008?source=see_link\">",
"     \"Control of ventilation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Prior to lung transplantation, patients with advanced lung disease adapt their breathing patterns to compensate for their underlying lung disease. Typically, patients with COPD have a shortened duty cycle (inspiratory time divided by the sum of inspiratory and expiratory times), while those with advanced cystic fibrosis and pulmonary fibrosis have an increased breathing frequency and decreased tidal volume. After lung transplantation, the breathing patterns (ie, frequency-to&ndash;tidal volume) of transplant recipients with COPD, cystic fibrosis, and pulmonary fibrosis breathing patterns during rest and exercise are similar to those of healthy subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/21\">",
"     21",
"    </a>",
"    ]. Among transplant recipients with COPD, the duty cycle-mean inspiratory flow pattern is also similar to healthy controls, suggesting that lung disease-based adaptations in breathing pattern are reversible with lung transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Oropharyngeal dysphagia, gastroesophageal reflux, and gastroparesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A spectrum of oropharyngeal and gastroesophageal disorders develops following lung transplantation. The pathogenesis is likely related to injury to the vagus, recurrent laryngeal, and superior laryngeal nerves at the time of surgery, or may be a continuation of preoperative disease.",
"   </p>",
"   <p>",
"    Postoperative development of swallowing difficulty was examined in a retrospective series of 263 lung transplant recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/22\">",
"     22",
"    </a>",
"    ]. Over 70 percent had laryngeal penetration or tracheal aspiration as assessed by fiberoptic endoscopic or video fluoroscopic swallowing studies. Of these, the majority had silent aspiration without any protective mechanism (eg, cough). In addition, vocal cord paresis was frequently identified (25 percent) when a formal swallowing evaluation was performed. The mechanism of oropharyngeal dysphagia is probably multifactorial, including gastroesophageal reflux (GERD), recurrent and superior laryngeal (sensory) nerve injury, and local trauma from endotracheal intubation and intraoperative transesophageal echocardiogram. In a follow-up study, patients with a normal swallowing evaluation had improved survival, although oropharyngeal dysphagia was not an independent risk factor for BOS [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Gastroesophageal dysfunction is common in patients with end-stage lung disease prior to lung transplantation. In one study of patients awaiting lung transplant, gastroesophageal reflux symptoms, esophageal dysmotility, abnormal pH probe testing, and delayed gastric emptying were reported in approximately 72, 33, 38, and 44 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/24\">",
"     24",
"    </a>",
"    ]. Pretransplant GERD may affect early outcomes after lung transplantation. Among 32 lung transplant recipients with objective evidence of GERD prior to transplantation, forced expiratory volume in one second (FEV",
"    <sub>",
"     1",
"    </sub>",
"    ) and survival at 18 months were decreased compared with 82 transplant recipients without GERD [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The incidence of gastroesophageal dysfunction appears to be further increased following lung transplant surgery. As examples [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/24,26-31\">",
"     24,26-31",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      GERD has been noted in 50 to 65 percent of transplant recipients [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/26-28,31\">",
"       26-28,31",
"      </a>",
"      ]. In a cohort of 23 transplant recipients, 35 percent had GERD before transplant; this increased to 65 percent post-transplant (based on 24 hour pH probe analysis) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/27\">",
"       27",
"      </a>",
"      ]. GERD was not associated with esophageal or gastric dysmotility. A lower prevalence (48 percent) of GERD was found in a study of 45 transplant recipients, although patients were tested later in their post-transplant course [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a study of gastric emptying, delayed emptying was noted in 50 percent of pre-transplant patients, 74 percent of recipients at three months post-transplant, and 63 percent at 12 months [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/32\">",
"       32",
"      </a>",
"      ]. A significant association was noted between pre- and post-transplant gastric emptying time and subsequent bronchiolitis obliterans syndrome (BOS) 0p (potential BOS), although associations with BOS 1 or higher did not achieve statistical significance (",
"      <a class=\"graphic graphic_table graphicRef70127 \" href=\"UTD.htm?24/21/24923\">",
"       table 1",
"      </a>",
"      ). In another study, delayed gastric emptying was noted in 39 of 43 lung transplant recipients at three months post-transplant and 17 of 21 at six months [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/24\">",
"       24",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/25/18841?source=see_link\">",
"       \"Chronic lung transplant rejection: Bronchiolitis obliterans\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Gastroparesis was reported in 6 percent of lung transplant recipients [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Bile acids were found in bronchoalveolar lavage (BAL) fluid in about half of 50 lung transplant recipients [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/24\">",
"       24",
"      </a>",
"      ]. This finding was confirmed in another series; in addition, while pepsin was generally present in BAL from lung transplant recipients, 70 percent of the patients with BOS had bile acid in their BAL fluid compared to 31 percent of stable patients [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/28\">",
"       28",
"      </a>",
"      ]. Furthermore, bile acid aspiration is associated with an increased rate of decline in FEV",
"      <sub>",
"       1",
"      </sub>",
"      , progression of BOS &gt;1, and decreased survival despite the use of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"       azithromycin",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Significantly higher BAL bile acid levels, neutrophilia, and IL-8 levels were detected in 12 lung transplant recipients with chronic Pseudomonas aeruginosa colonization, compared to 12 noncolonized controls [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/35\">",
"       35",
"      </a>",
"      ]. This finding highlights a possible association between reflux, aspiration, and chronic bacterial airway colonization.",
"     </li>",
"     <li>",
"      Nonacid or weakly acidic reflux, as detected by impedance-pH testing, also appears common among lung transplant recipients [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/28,36\">",
"       28,36",
"      </a>",
"      ]. In one study of 24 lung transplant recipients, the volume of reflux and an increase in nocturnal weakly acidic reflux events, even in the face of normal total reflux events, appeared to correlate with the presence of bile acids in BAL fluid [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Possible mechanisms underlying this enhanced risk of oropharyngeal and gastroesophageal disorders may include immune mechanisms triggered by microaspiration and injury to the vagus nerve and esophagus during transplant surgery, especially in heart-lung transplant patients due to the anastomosis in the posterior mediastinum [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/37-39\">",
"     37-39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Respiratory and skeletal muscle function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skeletal and respiratory muscle dysfunction are both observed in lung transplant recipients. The etiology is likely multifactorial; the principal mechanisms include deconditioning, critical care neuropathy, glucocorticoid related myopathy, and injury to the phrenic nerve.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Leg muscle weakness, a consistent finding in lung transplant patients, appears to be independent of the underlying pre-transplant diagnosis and type of surgery [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/18,40-44\">",
"       18,40-44",
"      </a>",
"      ]. As an example, a significant decrease in skeletal muscle strength, as measured by the quadriceps force, was found in 36 patients after lung transplantation [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/45\">",
"       45",
"      </a>",
"      ]. This decline correlated with the length of stay in the intensive care unit. Rehabilitation improved the skeletal muscle force and exercise tolerance, however, skeletal muscle weakness was still lower at three months compared to pre-transplant values [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/45\">",
"       45",
"      </a>",
"      ]. In another report, quadriceps force improved slightly by one year after lung transplantation [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In addition, lung transplantation had a more profound effect on exercise tolerance in female patients and their muscle strength recovered more slowly despite intensive rehabilitation [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/45\">",
"       45",
"      </a>",
"      ]. These findings suggest that deconditioning is not the only factor in the development of skeletal muscle weakness.",
"     </li>",
"     <li>",
"      A report of 12 patients found that the cumulative dose of glucocorticoids was an independent predictor of quadriceps atrophy, but not diaphragm or abdominal muscle weakness [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/40\">",
"       40",
"      </a>",
"      ]. In contrast, another study found both diaphragmatic and leg weakness after a brief course of high dose glucocorticoids, as given to treat acute rejection [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/47\">",
"       47",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/40/23173?source=see_link\">",
"       \"Glucocorticoid-induced myopathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The reported incidence of diaphragmatic paralysis due to phrenic nerve injury following lung transplantation has ranged from 3 to 30 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/48-50\">",
"       48-50",
"      </a>",
"      ]. In one series, phrenic nerve injury occurred more often in heart-lung, than single or double lung transplant recipients [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/49\">",
"       49",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/60/12233?source=see_link\">",
"       \"Noninfectious complications following lung transplantation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In contrast, diaphragmatic strength improves after lung transplantation in most patients with COPD. This is related to a decrease in lung volumes and the restoration of a more normal diaphragmatic configuration rather than an increase in strength [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/51,52\">",
"       51,52",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, abnormal skeletal muscle oxidative capacity and calcineurin inhibitor therapy, as suggested by experimental studies, may contribute to ongoing muscle weakness in transplant recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/53-56\">",
"     53-56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Sleep disordered breathing",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is unclear whether there is an increased incidence of sleep disordered breathing (SDB) in lung transplant recipients, as data are conflicting. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of 117 patients with end-stage lung disease awaiting lung transplantation, polysomnography (PSG) revealed SDB in 36 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/57\">",
"       57",
"      </a>",
"      ]. On repeat PSG post-transplantation, SDB had resolved in 6 of 11 recipients who had SDB preoperatively; however, 4 of 14 developed new onset SDB after transplantation. Overall, transplantation resulted in improved oxygenation during sleep and reduced the requirement for nocturnal respiratory support.",
"     </li>",
"     <li>",
"      In one series of 49 transplant recipients, 23 had obstructive sleep apnea on polysomnography [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/58\">",
"       58",
"      </a>",
"      ]. In another series of 24 recipients, 15 had SDB; nine of these patients had obstructive sleep apnea while six had central sleep apnea [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/59\">",
"       59",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      SDB and nocturnal desaturation were not observed in two smaller series of HLT recipients, although one study noted an increased breathing frequency during sleep, particularly among patients with restrictive PFTs [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/15,60\">",
"       15,60",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Potential contributing factors for sleep disordered breathing, if present following lung transplantation, include pharyngeal muscle dysfunction, glucocorticoid-induced central fat deposition, increased body mass index (BMI), pretransplantation sleep disordered breathing, and abnormal pulmonary function [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/57,61,62\">",
"     57,61,62",
"    </a>",
"    ]. In addition, lung transplantation may impair the reflexes that maintain upper airway patency during sleep and sedation, thus resulting in upper airway obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/58\">",
"     58",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/56/24454?source=see_link\">",
"     \"Mechanisms and anatomic sites of upper airway obstruction in obstructive sleep apnea in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with pulmonary arterial hypertension may exhibit nocturnal periodic breathing, similar to Cheyne-Stokes respiration; reversal of periodic breathing was reported in a patient with pulmonary hypertension following lung transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/63\">",
"     63",
"    </a>",
"    ]. Possible contributing factors to central sleep apnea in lung transplant recipients include lung denervation affecting the control of breathing, altered chemoreceptor sensitivity, and changes in respiratory drive due to transplant related medications [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     PULMONARY FUNCTION TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;After lung transplantation, pulmonary function tests (PFTs) typically reflect the pretransplant lung disease, the type of surgical procedure (eg, single, bilateral, heart-lung, or living lobar transplantation), and development of complications such as infection or graft rejection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Spirometry",
"    </span>",
"    &nbsp;&mdash;&nbsp;Over the first few months after transplantation, forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV",
"    <sub>",
"     1",
"    </sub>",
"    ) usually improve, generally reaching a plateau by one year. At this point, the postoperative values approach the recipient's predicted value (as determined by age, height, and gender). As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a retrospective review of BLT and SLT for COPD, post-transplant spirometry was obtained in 130 patients; the majority of improvement occurred in the first three months following SLT and BLT; slight further improvement continued up to 12 months after SLT and up to about 24 months in a few patients after BLT [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/64\">",
"       64",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a retrospective review of 33 HLT recipients, vital capacity (VC) and FEV",
"      <sub>",
"       1",
"      </sub>",
"      were 100 percent of predicted two months after transplant [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/65\">",
"       65",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Approximately 50 percent of bilateral lung transplant recipients have a flow volume loop pattern with a midvital capacity expiratory to inspiratory flow ratio",
"    <span class=\"nowrap\">",
"     (Ve50/Vi50)",
"    </span>",
"    greater than 1, a supranormal expiratory flow with a ratio of",
"    <span class=\"nowrap\">",
"     Ve50/FVC",
"    </span>",
"    <span class=\"nowrap\">",
"     &ge;1.5/sec,",
"    </span>",
"    and an absence of identifiable causes of extrathoracic obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/66\">",
"     66",
"    </a>",
"    ]. This pattern is associated with implantation of relatively larger donor lungs compared with the predicted volume of the recipient thorax. It is hypothesized that the mismatch in size could lead to increased lung elastic recoil or decreased airway resistance.",
"   </p>",
"   <p>",
"    Declines in the",
"    <span class=\"nowrap\">",
"     FEV",
"     <sub>",
"      1",
"     </sub>",
"     /FVC",
"    </span>",
"    ratio following lung transplantation, representing increased airflow obstruction, may be a manifestation of acute or chronic rejection, infection, or airway stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/67\">",
"     67",
"    </a>",
"    ]. When all other causes have been ruled out, an otherwise unexplained decline in FEV",
"    <sub>",
"     1",
"    </sub>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    FEF25-75 represents chronic allograft dysfunction, also known as bronchiolitis obliterans syndrome (BOS). BOS is defined as a persistent airflow obstruction with grading dependent on the severity of the reduction of FEV",
"    <sub>",
"     1",
"    </sub>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    FEF 25 to 75 (",
"    <a class=\"graphic graphic_table graphicRef70127 \" href=\"UTD.htm?24/21/24923\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/25/18841?source=see_link\">",
"     \"Chronic lung transplant rejection: Bronchiolitis obliterans\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Lung volumes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies have examined the time course and patterns of changes in lung volumes after lung transplant. In general, restrictive physiology is noted; total lung capacity (TLC) initially declines following lung transplantation, possibly due to respiratory muscle weakness (eg, from malnutrition, deconditioning, glucocorticoid use), pleural effusion, or phrenic nerve dysfunction.",
"   </p>",
"   <p>",
"    Characteristics of the recipient thoracic cage, as determined by the recipient's predicted or pretransplant TLC, appear to be the major determinant of TLC and VC in SLT, BLT, and HLT [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/68-71\">",
"     68-71",
"    </a>",
"    ]. In one study of 32 heart-lung transplant recipients, for example, the total lung capacity one year after surgery approached the recipients' pretransplant value, independent of the size of the donor lungs [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, some studies have found slightly different correlations [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/71-73\">",
"     71-73",
"    </a>",
"    ]. As an example, in a series of 71 standard, size matched (often slightly over sized) transplantations, postoperative TLC correlated with the recipients' pre-transplant value and donor predicted TLC [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/72\">",
"     72",
"    </a>",
"    ]. In contrast, in size reduced (eg, split-lung, segmental resection, lobectomy) and living lobar transplantation, the post-transplant lung volumes were more dependent on donor lung volumes [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/72\">",
"     72",
"    </a>",
"    ]. Total lung capacity in size reduced lung transplantation and FVC in LDLT can usually be estimated based on donor lung volumes adjusted to the number of segments implanted [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/72,73\">",
"     72,73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The relative contribution of the rib cage and abdominal compartments to end-inspiratory and end-expiratory chest wall volumes during exercise is similar in lung transplant recipients and healthy controls [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/21\">",
"     21",
"    </a>",
"    ]. In contrast, patients with end-stage lung disease have substantially smaller increases in inspiratory lung volumes (both ribcage and abdominal compartments) when comparing rest and peak exercise values.",
"   </p>",
"   <p>",
"    Additional factors that may affect the static and dynamic lung volumes in the post-transplant period include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Graft related airflow obstruction (eg, infection, acute and chronic rejection, anastomosis stenosis, dehiscence, and malacia, and also disease recurrence)",
"     </li>",
"     <li>",
"      Native lung related airflow obstruction (hyperinflation, disease progression)",
"     </li>",
"     <li>",
"      Restrictive ventilatory limitation without decrease of the",
"      <span class=\"nowrap\">",
"       FEV",
"       <sub>",
"        1",
"       </sub>",
"       /VC",
"      </span>",
"      ratio (chronic postoperative pain, increased body mass index, respiratory muscle weakness, rib fracture, pleural effusion, disease recurrence)",
"     </li>",
"     <li>",
"      Development of restrictive allograft syndrome (RAS), a form of chronic lung transplant rejection, is associated with a decline in total lung capacity and the appearance of interstitial lung disease on computed tomography [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/74,75\">",
"       74,75",
"      </a>",
"      ]. In contrast, patients with BOS have an obstructive pattern on spirometry and the chest radiograph is clear or shows hyperinflation and bronchiectasis. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Spirometry'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/25/18841?source=see_link\">",
"       \"Chronic lung transplant rejection: Bronchiolitis obliterans\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Gas transfer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Changes in diffusing capacity (DLCO) after lung transplantation are affected by the recipient's underlying lung disease and whether the transplant is an SLT or BLT [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/76\">",
"     76",
"    </a>",
"    ]. As an example, DLCO improved by 50 percent in patients with interstitial lung disease who received an SLT, compared with 150 and 300 percent in emphysema patients who received SLT and BLT, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Following heart-lung transplant, the distribution of perfusion and ventilation are normal and arterial blood gases are typically normal by eight weeks post-transplant [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/77\">",
"     77",
"    </a>",
"    ]. DLCO is reported to be normal to mildly reduced [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/78,79\">",
"     78,79",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Exercise function",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the absence of complications, heart-lung and lung transplant recipients experience improved functional capacity; however, a persistent exercise limitation remains regardless of the type of surgery or the underlying lung disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/43,46,80-90\">",
"     43,46,80-90",
"    </a>",
"    ]. Other solid organ transplant recipients exhibit a similar pattern of impairment [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/91-93\">",
"     91-93",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The physiologic changes in response to exercise are characterized by:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Reduced (40 to 60 percent predicted) peak oxygen consumption VO",
"      <sub>",
"       2",
"      </sub>",
"     </li>",
"     <li>",
"      Early onset of anaerobic threshold (at submaximal VO",
"      <sub>",
"       2",
"      </sub>",
"      )",
"     </li>",
"     <li>",
"      Normal gas exchange",
"     </li>",
"     <li>",
"      Adequate heart rate reserve",
"     </li>",
"     <li>",
"      Sufficient cardiac output to maintain the workload reached",
"     </li>",
"     <li>",
"      Absence of ventilatory or cardiac limiting factors",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Oxygenation remains normal during peak incremental and steady state exercise in HLT and BLT patients as well as in SLT patients with obstructive lung disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/81,82,85,94,95\">",
"     81,82,85,94,95",
"    </a>",
"    ]. However, mild exercise desaturation may be seen in SLT recipients with restrictive parenchymal or pulmonary vascular disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/80,81\">",
"     80,81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pattern of exercise limitation is most compatible with skeletal muscle dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/41,53,96\">",
"     41,53,96",
"    </a>",
"    ]. Impaired oxidative capacity (O",
"    <sub>",
"     2",
"    </sub>",
"    uptake and utilization) may be due to pre-transplant deconditioning, muscle atrophy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    adverse affects of immunosuppressive drugs (eg, glucocorticoids).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Operation specific changes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The specific transplant procedure, whether SLT, BLT, HLT or LDLT, influences the post-transplant pulmonary function test results.",
"   </p>",
"   <p>",
"    With SLT, static and dynamic lung volumes depend to some extent on the physiologic properties of the remaining native lung:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study of patients with pulmonary fibrosis, vital capacity following SLT increased from a mean preoperative value of 43 percent to 69 percent of predicted at one year [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/97\">",
"       97",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In SLT recipients with obstructive lung disease, the FEV",
"      <sub>",
"       1",
"      </sub>",
"      can rise to 50 to 57 percent of predicted and mild elevation of TLC persists [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/89,98-101\">",
"       89,98-101",
"      </a>",
"      ]. After SLT for obstructive lung disease, approximately 80 percent of both the ventilation and perfusion are distributed to the transplant allograft [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/80\">",
"       80",
"      </a>",
"      ]. In contrast, following SLT for restrictive lung disease, a similar pattern of perfusion is seen, but only 60 to 70 percent of the total ventilation is directed to the transplanted lung [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/80,97\">",
"       80,97",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In SLT recipients with acute rejection, blood flow is usually redirected away from the transplanted lung; this can lead to substantial ventilation-perfusion mismatch and hypoxemia [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/102\">",
"       102",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Following BLT, the original pathological process has little impact upon the pulmonary function of the graft. FEV",
"    <sub>",
"     1",
"    </sub>",
"    , FVC and TLC are generally in the low normal range at six to nine months post-transplantation with an average FEV",
"    <sub>",
"     1",
"    </sub>",
"    of 78 to 85 percent predicted and FVC of 66 to 92 percent predicted [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/89,98,99,103\">",
"     89,98,99,103",
"    </a>",
"    ]. Following HLT, pulmonary function testing shows a mild restrictive ventilatory pattern [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Lung volumes in living donor lobar lung transplantation (LDLT) recipients usually progressively increase up to 12 months post-transplantation, similar to SLT and BLT patients [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/73,104\">",
"     73,104",
"    </a>",
"    ]. In LDLT, allograft FVC can be estimated based on the donor lung FVC and the number of pulmonary segments implanted and correlates well with the recipients' measured post-transplant values [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/73\">",
"     73",
"    </a>",
"    ]. Maximum workload at peak exercise, maximum heart rate, peak VO",
"    <sub>",
"     2",
"    </sub>",
"    , oxygen consumption at anaerobic threshold, and the ability to maintain O",
"    <sub>",
"     2",
"    </sub>",
"    saturation were similar in LDLT and cadaveric bilateral transplant recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/104\">",
"     104",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the transplantation of significantly less lung tissue, pulmonary function with LDLT appears to approximate that observed with deceased donor BLT by six months post-transplant. In one study comparing two transplantation procedures (living donor lobar (LDLT) versus deceased donor BLT), the first and third post-transplant month values were significantly lower in the LDLT group, but by 6 months there was no difference between them [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/104\">",
"     104",
"    </a>",
"    ]. This was true even after the subgroup analysis of recipients with &lt;two years and &gt;two years survival. Forced vital capacity increased to a mean of 63.6 percent of predicted, FEV",
"    <sub>",
"     1",
"    </sub>",
"    to the mean of 64.5 percent of predicted by six months post-transplantation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     DISEASE SPECIFIC CHANGES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The underlying lung disease for which transplantation is performed and the type of transplantation procedure influence postoperative respiratory physiology. Disease specific survival following the various lung transplant procedures is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/29/31192?source=see_link\">",
"     \"Lung transplantation: Disease-based choice of procedure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     COPD/emphysema",
"    </span>",
"    &nbsp;&mdash;&nbsp;Single lung (SLT) and bilateral lung (BLT) transplantation are performed for patients with",
"    <span class=\"nowrap\">",
"     COPD/emphysema.",
"    </span>",
"    With both procedures, forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV",
"    <sub>",
"     1",
"    </sub>",
"    ) increase compared with pretransplant values. However, some differences in post-transplantation respiratory function after SLT compared with BLT have been observed [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/64,99,105,106\">",
"     64,99,105,106",
"    </a>",
"    ]. As an example, a retrospective review comparing spirometry results after BLT and SLT found that FVC was about 10 percent higher at one and five years following BLT, and FEV",
"    <sub>",
"     1",
"    </sub>",
"    was about 15 to 20 percent higher at the same time points [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/107\">",
"     107",
"    </a>",
"    ]. Similar results were found in a smaller series that also found a 30 percent increase in the distance walked in six minutes (6MWT) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In an observational study of patients with COPD, physical activity as measured by a pedometer was significantly greater (6642 versus 1407 steps) among 47 lung transplant recipients compared with 15 lung transplant candidates; lower extremity strength and FEV",
"    <sub>",
"     1",
"    </sub>",
"    were also improved [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/108\">",
"     108",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A small study of SLT in 19 patients with emphysema found that donor lung volume was slightly more than half what was expected based on donor predicted values [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/109\">",
"     109",
"    </a>",
"    ]. The reduction in lung volume was predominantly related to a lower chest wall volume and partially related to continued hyperinflation of the emphysematous native lung. A decrease in inspiratory muscle strength appeared to contribute to the decreased chest wall volume.",
"   </p>",
"   <p>",
"    There is no statistical difference between a left versus a right SLT in terms of pulmonary function test results and graded exercise results. A trend towards a greater increase of FEV",
"    <sub>",
"     1",
"    </sub>",
"    and FVC with right SLT has been observed and is most likely due to the larger size of the right lung [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/110\">",
"     110",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Cystic fibrosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;BLT is the procedure of choice in chronic suppurative lung diseases such as cystic fibrosis (CF); however, occasionally HLT or living donor lobar transplantation (LDLT) are performed.",
"   </p>",
"   <p>",
"    Following BLT or HLT for cystic fibrosis, the FEV",
"    <sub>",
"     1",
"    </sub>",
"    generally increases to 70 to 80 percent of predicted for the recipient and remains stable in the absence of other complications [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/111-117\">",
"     111-117",
"    </a>",
"    ]. LDLT recipients are reported to have lung function comparable to that of BLT recipients of deceased donor lungs at one year post-transplant [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/104\">",
"     104",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hemodynamic analysis at one year following LDLT revealed normal pulmonary artery pressures and pulmonary vascular resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/118\">",
"     118",
"    </a>",
"    ]. This demonstrates the ability of two lobes to accept the entire cardiac output.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Interstitial lung diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both single and bilateral lung transplantation are employed in patients with interstitial lung diseases (ILD); in one study there was no statistical difference in pulmonary function test results after transplantation when the two methods were compared [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/119\">",
"     119",
"    </a>",
"    ]. There was a trend towards slightly increased mean FEV",
"    <sub>",
"     1",
"    </sub>",
"    in BLT recipients, but there was no significant difference in terms of exercise capacity.",
"   </p>",
"   <p>",
"    Post-transplant VC in transplant recipients closely correlates with the predicted normal VC of the donor after left SLT. In contrast, VC may be the same or smaller than the predicted normal VC of the recipient in right SLT [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/71,83\">",
"     71,83",
"    </a>",
"    ]. This may be explained by the ability of the left hemithorax to accommodate a larger donor organ by the descent of the diaphragm to a normal position and by the shift of the mediastinum to the right.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Pulmonary arterial hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bilateral lung transplantation is the procedure of choice for patients with pulmonary arterial hypertension (PAH); heart-lung transplantation is performed on rare occasions (eg, compromised left ventricle function). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/47/19193?source=see_link\">",
"     \"Overview of pulmonary hypertension in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The main physiologic changes that specifically apply to patients with PAH are hemodynamic and are mostly related to the type of transplant surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/99,120-125\">",
"     99,120-125",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cardiac index, mean pulmonary artery pressure, and pulmonary vascular resistance usually return to normal after HLT or BLT.",
"     </li>",
"     <li>",
"      Mean pulmonary artery pressure and pulmonary vascular resistance decrease significantly after SLT. However, improvement in the hemodynamic outcome parameters remains inferior to BLT or HLT [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/126\">",
"       126",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Hemodynamic parameters during exercise continue to be abnormal after BLT in some patients. As an example, in a series of nine BLT recipients, there was a tendency towards lower cardiac output during exercise; cardiac stroke volume index and oxygen pulse were significantly reduced compared with 37 normal subjects [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/125\">",
"       125",
"      </a>",
"      ]. Pulmonary artery systolic pressure exceeded 40 mmHg during exercise in three of the BLT recipients.",
"     </li>",
"     <li>",
"      SLT may be complicated by",
"      <span class=\"nowrap\">",
"       ventilation/perfusion",
"      </span>",
"      mismatch and hypoxemia in the setting of acute rejection or donor lung infection, when ventilation usually shifts to the native lung [",
"      <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/120-123,127,128\">",
"       120-123,127,128",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Following BLT, a sudden decrease in pulmonary artery pressure may lead to a decrease in the cavity of the hypertrophied right ventricular (RV) resulting in ventricular outflow obstruction. This somewhat unusual complication can be diagnosed by transesophageal echocardiography; once this is recognized, cessation of inotropic agents may lead to hemodynamic improvement [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/129\">",
"     129",
"    </a>",
"    ]. Left ventricular dysfunction can also transiently occur in the setting of restored RV function, likely due to a compliance disorder of the small left ventricle (LV) and paradoxical ventricular septal movements [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/124\">",
"     124",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Reverse remodeling of the right ventricle has been shown to occur after lung transplantation for PAH. In general, patients demonstrate significant and sustained improvements in right ventricular function by echocardiography [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/99,121,123,130,131\">",
"     99,121,123,130,131",
"    </a>",
"    ]. In addition, tricuspid regurgitation improves and flattening of the intraventricular septum disappears. These findings were demonstrated in a cohort of 14 patients with PAH who had normal RV size at three months after BLT [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/131\">",
"     131",
"    </a>",
"    ]. However, improvements in right ventricular hypertrophy may not occur immediately post-transplant [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/121\">",
"     121",
"    </a>",
"    ]. Instead, RV hypertrophy regresses as part of the long-term reverse remodeling process.",
"   </p>",
"   <p>",
"    <strong>",
"     Secondary pulmonary hypertension",
"    </strong>",
"    &mdash; In contrast to patients with pulmonary arterial hypertension (PAH), those with secondary pulmonary hypertension (SPH) experience only modest and heterogeneous improvements in hemodynamics after transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/132\">",
"     132",
"    </a>",
"    ]. One group reported improved right ventricular function after transplant in only two of six patients with SPH [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/130\">",
"     130",
"    </a>",
"    ]. In contrast, a larger study of 45 patients with SPH demonstrated a significant decrease in pulmonary arterial pressure in transplant recipients with both low and high preoperative SPH [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/133\">",
"     133",
"    </a>",
"    ]. Single lung transplantation was found to be an acceptable method for patients with SPH. In this study, more severe SPH was not associated with adverse outcome despite the more frequent use of cardiopulmonary bypass, greater reperfusion lung injury, and greater dependence on nitric oxide and oxygen [",
"    <a class=\"abstract\" href=\"UTD.htm?16/50/17194/abstract/133\">",
"     133",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A variety of physiologic changes occur following lung transplantation; some affect all lung transplant recipients, while others may be dependent on the type of lung transplant surgery performed (single lung transplantation (SLT), bilateral lung transplantation (BLT), heart-lung transplantation (HLT), and living donor lobar transplantation (LDLT)), or on the pre-transplant diagnosis. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When donor lungs are harvested, vagal and autonomic nerves, and also pulmonary, bronchial, and lymphatic vessels are all interrupted. One of the interrupted nerves is the afferent limb of the cough reflex; coughing can be stimulated from a remaining native lung or from sites in the respiratory tract proximal to the airway anastomosis, but may be blunted in the transplanted lung. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Anatomic changes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Following lung and heart-lung transplantation, gastroesophageal reflux symptoms, esophageal dysmotility, and delayed gastric emptying are frequent. As a consequence of gastroesophageal dysmotility, aspiration of gastric and bile acids may occur and contribute to bronchiolitis obliterans syndrome. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Oropharyngeal dysphagia, gastroesophageal reflux, and gastroparesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diaphragmatic strength improves after lung transplantation in most patients with COPD, however diaphragmatic paralysis may occur in 3 to 30 percent of transplant recipients, more commonly those receiving HLT. Skeletal muscle strength is reduced in most transplant recipients, probably due to deconditioning and effects of immunosuppressive medications post-transplant. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Respiratory and skeletal muscle function'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV",
"      <sub>",
"       1",
"      </sub>",
"      ) usually improve over first 3 months following SLT and BLT; slight further improvement occurs up to about 24 months after BLT. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Pulmonary function testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the absence of complications, lung transplant recipients experience improved functional capacity; however, a persistent exercise limitation remains regardless of the type of surgery or the underlying lung disease. In part, this is caused by skeletal muscle dysfunction from deconditioning and medications. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Exercise function'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Following BLT or HLT for pulmonary arterial hypertension (PAH), cardiac index, mean pulmonary artery pressure, and pulmonary vascular resistance usually return to normal. After SLT for PAH, mean pulmonary artery pressure and pulmonary vascular resistance decrease significantly, but cardiac index is less likely to improve. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Disease specific changes'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/1\">",
"      Glanville AR, Gabb GM, Theodore J, Robin ED. Bronchial responsiveness to exercise after human cardiopulmonary transplantation. Chest 1989; 96:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/2\">",
"      Herve P, Picard N, Le Roy Ladurie M, et al. Lack of bronchial hyperresponsiveness to methacholine and to isocapnic dry air hyperventilation in heart/lung and double-lung transplant recipients with normal lung histology. The Paris-Sud Lung Transplant Group. Am Rev Respir Dis 1992; 145:1503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/3\">",
"      Higenbottam T, Jackson M, Rashdi T, et al. Lung rejection and bronchial hyperresponsiveness to methacholine and ultrasonically nebulized distilled water in heart-lung transplantation patients. Am Rev Respir Dis 1989; 140:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/4\">",
"      Maurer JR, McLean PA, Cooper JD, et al. Airway hyperreactivity in patients undergoing lung and heart/lung transplantation. Am Rev Respir Dis 1989; 139:1038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/5\">",
"      Glanville AR, Theodore J, Baldwin JC, Robin ED. Bronchial responsiveness after human heart-lung transplantation. Chest 1990; 97:1360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/6\">",
"      Liakakos P, Snell GI, Ward C, et al. Bronchial hyperresponsiveness in lung transplant recipients: lack of correlation with airway inflammation. Thorax 1997; 52:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/7\">",
"      Stanbrook MB, Kesten S. Bronchial hyperreactivity after lung transplantation predicts early bronchiolitis obliterans. Am J Respir Crit Care Med 1999; 160:2034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/8\">",
"      Rajagopalan N, Maurer J, Kesten S. Bronchodilator response at low lung volumes predicts bronchiolitis obliterans in lung transplant recipients. Chest 1996; 109:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/9\">",
"      Van Muylem A, Paiva M, Estenne M. Involvement of peripheral airways during methacholine-induced bronchoconstriction after lung transplantation. Am J Respir Crit Care Med 2001; 164:1200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/10\">",
"      Higenbottam T, Jackson M, Woolman P, et al. The cough response to ultrasonically nebulized distilled water in heart-lung transplantation patients. Am Rev Respir Dis 1989; 140:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/11\">",
"      D'Ovidio F, Mura M, Tsang M, et al. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation. J Thorac Cardiovasc Surg 2005; 129:1144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/12\">",
"      Herve P, Silbert D, Cerrina J, et al. Impairment of bronchial mucociliary clearance in long-term survivors of heart/lung and double-lung transplantation. The Paris-Sud Lung Transplant Group. Chest 1993; 103:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/13\">",
"      Read RC, Shankar S, Rutman A, et al. Ciliary beat frequency and structure of recipient and donor epithelia following lung transplantation. Eur Respir J 1991; 4:796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/14\">",
"      Veale D, Glasper PN, Gascoigne A, et al. Ciliary beat frequency in transplanted lungs. Thorax 1993; 48:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/15\">",
"      Sanders MH, Costantino JP, Owens GR, et al. Breathing during wakefulness and sleep after human heart-lung transplantation. Am Rev Respir Dis 1989; 140:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/16\">",
"      Sanders MH, Owens GR, Sciurba FC, et al. Ventilation and breathing pattern during progressive hypercapnia and hypoxia after human heart-lung transplantation. Am Rev Respir Dis 1989; 140:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/17\">",
"      Duncan SR, Kagawa FT, Starnes VA, Theodore J. Hypercarbic ventilatory responses of human heart-lung transplant recipients. Am Rev Respir Dis 1991; 144:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/18\">",
"      Frost AE, Zamel N, McClean P, et al. Hypercapnic ventilatory response in recipients of double-lung transplants. Am Rev Respir Dis 1992; 146:1610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/19\">",
"      Trachiotis GD, Knight SR, Hann M, et al. Respiratory responses to CO2 rebreathing in lung transplant recipients. Ann Thorac Surg 1994; 58:1709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/20\">",
"      Trachiotis GD, Knight SR, Pohl MS, et al. Tidal volume and respiratory rate changes during CO2 rebreathing after lung transplantation. Ann Thorac Surg 1994; 58:1718.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/21\">",
"      Wilkens H, Weingard B, Lo Mauro A, et al. Breathing pattern and chest wall volumes during exercise in patients with cystic fibrosis, pulmonary fibrosis and COPD before and after lung transplantation. Thorax 2010; 65:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/22\">",
"      Atkins BZ, Trachtenberg MS, Prince-Petersen R, et al. Assessing oropharyngeal dysphagia after lung transplantation: altered swallowing mechanisms and increased morbidity. J Heart Lung Transplant 2007; 26:1144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/23\">",
"      Atkins BZ, Petersen RP, Daneshmand MA, et al. Impact of oropharyngeal dysphagia on long-term outcomes of lung transplantation. Ann Thorac Surg 2010; 90:1622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/24\">",
"      D'Ovidio F, Mura M, Ridsdale R, et al. The effect of reflux and bile acid aspiration on the lung allograft and its surfactant and innate immunity molecules SP-A and SP-D. Am J Transplant 2006; 6:1930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/25\">",
"      Murthy SC, Nowicki ER, Mason DP, et al. Pretransplant gastroesophageal reflux compromises early outcomes after lung transplantation. J Thorac Cardiovasc Surg 2011; 142:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/26\">",
"      D'Ovidio F, Keshavjee S. Gastroesophageal reflux and lung transplantation. Dis Esophagus 2006; 19:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/27\">",
"      Young LR, Hadjiliadis D, Davis RD, Palmer SM. Lung transplantation exacerbates gastroesophageal reflux disease. Chest 2003; 124:1689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/28\">",
"      Blondeau K, Mertens V, Vanaudenaerde BA, et al. Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection. Eur Respir J 2008; 31:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/29\">",
"      Sodhi SS, Guo JP, Maurer AH, et al. Gastroparesis after combined heart and lung transplantation. J Clin Gastroenterol 2002; 34:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/30\">",
"      Hopkins PM, Kermeen F, Duhig E, et al. Oil red O stain of alveolar macrophages is an effective screening test for gastroesophageal reflux disease in lung transplant recipients. J Heart Lung Transplant 2010; 29:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/31\">",
"      Davis CS, Shankaran V, Kovacs EJ, et al. Gastroesophageal reflux disease after lung transplantation: pathophysiology and implications for treatment. Surgery 2010; 148:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/32\">",
"      Raviv Y, D'Ovidio F, Pierre A, et al. Prevalence of gastroparesis before and after lung transplantation and its association with lung allograft outcomes. Clin Transplant 2011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/33\">",
"      Paul S, Escareno CE, Clancy K, et al. Gastrointestinal complications after lung transplantation. J Heart Lung Transplant 2009; 28:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/34\">",
"      Mertens V, Blondeau K, Van Oudenhove L, et al. Bile acids aspiration reduces survival in lung transplant recipients with BOS despite azithromycin. Am J Transplant 2011; 11:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/35\">",
"      Vos R, Blondeau K, Vanaudenaerde BM, et al. Airway colonization and gastric aspiration after lung transplantation: do birds of a feather flock together? J Heart Lung Transplant 2008; 27:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/36\">",
"      Blondeau K, Mertens V, Vanaudenaerde BA, et al. Nocturnal weakly acidic reflux promotes aspiration of bile acids in lung transplant recipients. J Heart Lung Transplant 2009; 28:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/37\">",
"      Suen HC, Hendrix H, Patterson GA. Physiologic consequences of pneumonectomy. Consequences on the esophageal function. Chest Surg Clin N Am 1999; 9:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/38\">",
"      Bobadilla JL, Jankowska-Gan E, Xu Q, et al. Reflux-induced collagen type v sensitization: potential mediator of bronchiolitis obliterans syndrome. Chest 2010; 138:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/39\">",
"      Neujahr DC, Mohammed A, Ulukpo O, et al. Surgical correction of gastroesophageal reflux in lung transplant patients is associated with decreased effector CD8 cells in lung lavages: a case series. Chest 2010; 138:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/40\">",
"      Pinet C, Scillia P, Cassart M, et al. Preferential reduction of quadriceps over respiratory muscle strength and bulk after lung transplantation for cystic fibrosis. Thorax 2004; 59:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/41\">",
"      Lands LC, Smountas AA, Mesiano G, et al. Maximal exercise capacity and peripheral skeletal muscle function following lung transplantation. J Heart Lung Transplant 1999; 18:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/42\">",
"      Pantoja JG, Andrade FH, Stoki DS, et al. Respiratory and limb muscle function in lung allograft recipients. Am J Respir Crit Care Med 1999; 160:1205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/43\">",
"      Ambrosino N, Bruschi C, Callegari G, et al. Time course of exercise capacity, skeletal and respiratory muscle performance after heart-lung transplantation. Eur Respir J 1996; 9:1508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/44\">",
"      Wang XN, Williams TJ, McKenna MJ, et al. Skeletal muscle oxidative capacity, fiber type, and metabolites after lung transplantation. Am J Respir Crit Care Med 1999; 160:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/45\">",
"      Maury G, Langer D, Verleden G, et al. Skeletal muscle force and functional exercise tolerance before and after lung transplantation: a cohort study. Am J Transplant 2008; 8:1275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/46\">",
"      Reinsma GD, ten Hacken NH, Grevink RG, et al. Limiting factors of exercise performance 1 year after lung transplantation. J Heart Lung Transplant 2006; 25:1310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/47\">",
"      Nava S, Fracchia C, Callegari G, et al. Weakness of respiratory and skeletal muscles after a short course of steroids in patients with acute lung rejection. Eur Respir J 2002; 20:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/48\">",
"      Maziak DE, Maurer JR, Kesten S. Diaphragmatic paralysis: a complication of lung transplantation. Ann Thorac Surg 1996; 61:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/49\">",
"      Ferdinande P, Bruyninckx F, Van Raemdonck D, et al. Phrenic nerve dysfunction after heart-lung and lung transplantation. J Heart Lung Transplant 2004; 23:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/50\">",
"      Sheridan PH Jr, Cheriyan A, Doud J, et al. Incidence of phrenic neuropathy after isolated lung transplantation. The Loyola University Lung Transplant Group. J Heart Lung Transplant 1995; 14:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/51\">",
"      Wanke T, Merkle M, Formanek D, et al. Effect of lung transplantation on diaphragmatic function in patients with chronic obstructive pulmonary disease. Thorax 1994; 49:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/52\">",
"      Brath H, Lahrmann H, Wanke T, et al. The effect of lung transplantation on the neural drive to the diaphragm in patients with severe COPD. Eur Respir J 1997; 10:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/53\">",
"      Evans AB, Al-Himyary AJ, Hrovat MI, et al. Abnormal skeletal muscle oxidative capacity after lung transplantation by 31P-MRS. Am J Respir Crit Care Med 1997; 155:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/54\">",
"      Keller C, Hellsten Y, Steensberg A, Pedersen BK. Differential regulation of IL-6 and TNF-alpha via calcineurin in human skeletal muscle cells. Cytokine 2006; 36:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/55\">",
"      Dunn SE, Burns JL, Michel RN. Calcineurin is required for skeletal muscle hypertrophy. J Biol Chem 1999; 274:21908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/56\">",
"      Zbreski MG, Helwig BG, Mitchell KE, et al. Effects of cyclosporine-A on rat soleus muscle fiber size and phenotype. Med Sci Sports Exerc 2006; 38:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/57\">",
"      Malouf MA, Milrose MA, Milross MA, et al. Sleep-disordered breathing before and after lung transplantation. J Heart Lung Transplant 2008; 27:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/58\">",
"      Chhajed PN, Aboyoun C, Malouf MA, et al. Management of acute hypoxemia during flexible bronchoscopy with insertion of a nasopharyngeal tube in lung transplant recipients. Chest 2002; 121:1350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/59\">",
"      Naraine VS, Bradley TD, Singer LG. Prevalence of sleep disordered breathing in lung transplant recipients. J Clin Sleep Med 2009; 5:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/60\">",
"      Shea SA, Horner RL, Banner NR, et al. The effect of human heart-lung transplantation upon breathing at rest and during sleep. Respir Physiol 1988; 72:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/61\">",
"      Pascual N, Jurado B, Rubio JM, et al. Respiratory disorders and quality of sleep in patients on the waiting list for lung transplantation. Transplant Proc 2005; 37:1537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/62\">",
"      Singer LG, Brazelton TR, Doyle RL, et al. Weight gain after lung transplantation. J Heart Lung Transplant 2003; 22:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/63\">",
"      Schulz R, Fegbeutel C, Olschewski H, et al. Reversal of nocturnal periodic breathing in primary pulmonary hypertension after lung transplantation. Chest 2004; 125:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/64\">",
"      Pochettino A, Kotloff RM, Rosengard BR, et al. Bilateral versus single lung transplantation for chronic obstructive pulmonary disease: intermediate-term results. Ann Thorac Surg 2000; 70:1813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/65\">",
"      Van Muylem A, M&eacute;lot C, Antoine M, et al. Role of pulmonary function in the detection of allograft dysfunction after heart-lung transplantation. Thorax 1997; 52:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/66\">",
"      Eberlein M, Permutt S, Brown RH, et al. Supranormal expiratory airflow after bilateral lung transplantation is associated with improved survival. Am J Respir Crit Care Med 2011; 183:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/67\">",
"      Morlion B, Knoop C, Paiva M, Estenne M. Internet-based home monitoring of pulmonary function after lung transplantation. Am J Respir Crit Care Med 2002; 165:694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/68\">",
"      Otulana BA, Mist BA, Scott JP, et al. The effect of recipient lung size on lung physiology after heart-lung transplantation. Transplantation 1989; 48:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/69\">",
"      Lloyd KS, Barnard P, Holland VA, et al. Pulmonary function after heart-lung transplantation using larger donor organs. Am Rev Respir Dis 1990; 142:1026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/70\">",
"      Park SJ, Houck J, Pifarre R, et al. Optimal size matching in single lung transplantation. J Heart Lung Transplant 1995; 14:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/71\">",
"      Miyoshi S, Demertzis S, Eckstein F, et al. Chest size matching in single and double lung transplantation. Jpn J Thorac Cardiovasc Surg 1999; 47:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/72\">",
"      Aigner C, Jaksch P, Taghavi S, et al. Donor total lung capacity predicts recipient total lung capacity after size-reduced lung transplantation. J Heart Lung Transplant 2005; 24:2098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/73\">",
"      Date H, Aoe M, Nagahiro I, et al. How to predict forced vital capacity after living-donor lobar-lung transplantation. J Heart Lung Transplant 2004; 23:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/74\">",
"      Sato M, Waddell TK, Wagnetz U, et al. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. J Heart Lung Transplant 2011; 30:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/75\">",
"      Woodrow JP, Shlobin OA, Barnett SD, et al. Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation. J Heart Lung Transplant 2010; 29:1159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/76\">",
"      Miyoshi S, Mochizuki Y, Nagai S, et al. Physiologic aspects in human lung transplantation. Ann Thorac Cardiovasc Surg 2005; 11:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/77\">",
"      Glanville AR, Imoto E, Baldwin JC, et al. The role of right ventricular endomyocardial biopsy in the long-term management of heart-lung transplant recipients. J Heart Transplant 1987; 6:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/78\">",
"      Theodore J, Jamieson SW, Burke CM, et al. Physiologic aspects of human heart-lung transplantation. Pulmonary function status of the post-transplanted lung. Chest 1984; 86:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/79\">",
"      Otulana BA, Higenbottam TW, Wallwork J. Causes of exercise limitation after heart-lung transplantation. J Heart Lung Transplant 1992; 11:S244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/80\">",
"      Gibbons WJ, Levine SM, Bryan CL, et al. Cardiopulmonary exercise responses after single lung transplantation for severe obstructive lung disease. Chest 1991; 100:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/81\">",
"      Levy RD, Ernst P, Levine SM, et al. Exercise performance after lung transplantation. J Heart Lung Transplant 1993; 12:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/82\">",
"      Williams TJ, Patterson GA, McClean PA, et al. Maximal exercise testing in single and double lung transplant recipients. Am Rev Respir Dis 1992; 145:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/83\">",
"      Miyoshi S, Schaefers HJ, Trulock EP, et al. Donor selection for single and double lung transplantation. Chest size matching and other factors influencing posttransplantation vital capacity. Chest 1990; 98:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/84\">",
"      Howard DK, Iademarco EJ, Trulock EP. The role of cardiopulmonary exercise testing in lung and heart-lung transplantation. Clin Chest Med 1994; 15:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/85\">",
"      Theodore J, Morris AJ, Burke CM, et al. Cardiopulmonary function at maximum tolerable constant work rate exercise following human heart-lung transplantation. Chest 1987; 92:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/86\">",
"      Ross DJ, Waters PF, Mohsenifar Z, et al. Hemodynamic responses to exercise after lung transplantation. Chest 1993; 103:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/87\">",
"      Vachi&eacute;ry JL, Niset G, Antoine M, et al. Haemodynamic response to dynamic exercise after heart-lung transplantation. Eur Respir J 1999; 14:1131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/88\">",
"      Schwaiblmair M, Reichenspurner H, M&uuml;ller C, et al. Cardiopulmonary exercise testing before and after lung and heart-lung transplantation. Am J Respir Crit Care Med 1999; 159:1277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/89\">",
"      Orens JB, Becker FS, Lynch JP 3rd, et al. Cardiopulmonary exercise testing following allogeneic lung transplantation for different underlying disease states. Chest 1995; 107:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/90\">",
"      Langer D, Gosselink R, Pitta F, et al. Physical activity in daily life 1 year after lung transplantation. J Heart Lung Transplant 2009; 28:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/91\">",
"      Kavanagh T, Yacoub MH, Mertens DJ, et al. Cardiorespiratory responses to exercise training after orthotopic cardiac transplantation. Circulation 1988; 77:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/92\">",
"      Kempeneers G, Noakes TD, van Zyl-Smit R, et al. Skeletal muscle limits the exercise tolerance of renal transplant recipients: effects of a graded exercise training program. Am J Kidney Dis 1990; 16:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/93\">",
"      Stephenson AL, Yoshida EM, Abboud RT, et al. Impaired exercise performance after successful liver transplantation. Transplantation 2001; 72:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/94\">",
"      Kimoff RJ, Cheong TH, Cosio MG, et al. Pulmonary denervation in humans. Effects on dyspnea and ventilatory pattern during exercise. Am Rev Respir Dis 1990; 142:1034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/95\">",
"      Miyoshi S, Trulock EP, Schaefers HJ, et al. Cardiopulmonary exercise testing after single and double lung transplantation. Chest 1990; 97:1130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/96\">",
"      Tirdel GB, Girgis R, Fishman RS, Theodore J. Metabolic myopathy as a cause of the exercise limitation in lung transplant recipients. J Heart Lung Transplant 1998; 17:1231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/97\">",
"      Grossman RF, Frost A, Zamel N, et al. Results of single-lung transplantation for bilateral pulmonary fibrosis. The Toronto Lung Transplant Group. N Engl J Med 1990; 322:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/98\">",
"      Trulock EP, Cooper JD, Kaiser LR, et al. The Washington University-Barnes Hospital experience with lung transplantation. Washington University Lung Transplantation Group. JAMA 1991; 266:1943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/99\">",
"      Bando K, Paradis IL, Keenan RJ, et al. Comparison of outcomes after single and bilateral lung transplantation for obstructive lung disease. J Heart Lung Transplant 1995; 14:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/100\">",
"      Mal H, Sleiman C, Jebrak G, et al. Functional results of single-lung transplantation for chronic obstructive lung disease. Am J Respir Crit Care Med 1994; 149:1476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/101\">",
"      Patterson GA, Maurer JR, Williams TJ, et al. Comparison of outcomes of double and single lung transplantation for obstructive lung disease. The Toronto Lung Transplant Group. J Thorac Cardiovasc Surg 1991; 101:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/102\">",
"      Levine SM, Jenkinson SG, Bryan CL, et al. Ventilation-perfusion inequalities during graft rejection in patients undergoing single lung transplantation for primary pulmonary hypertension. Chest 1992; 101:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/103\">",
"      Williams TJ, Grossman RF, Maurer JR. Long-term functional follow-up of lung transplant recipients. Clin Chest Med 1990; 11:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/104\">",
"      Bowdish ME, Pessotto R, Barbers RG, et al. Long-term pulmonary function after living-donor lobar lung transplantation in adults. Ann Thorac Surg 2005; 79:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/105\">",
"      Sundaresan RS, Shiraishi Y, Trulock EP, et al. Single or bilateral lung transplantation for emphysema? J Thorac Cardiovasc Surg 1996; 112:1485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/106\">",
"      Cassivi SD, Meyers BF, Battafarano RJ, et al. Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg 2002; 74:1663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/107\">",
"      Mason DP, Rajeswaran J, Murthy SC, et al. Spirometry after transplantation: how much better are two lungs than one? Ann Thorac Surg 2008; 85:1193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/108\">",
"      Bossenbroek L, ten Hacken NH, van der Bij W, et al. Cross-sectional assessment of daily physical activity in chronic obstructive pulmonary disease lung transplant patients. J Heart Lung Transplant 2009; 28:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/109\">",
"      Loring SH, Mentzer SJ, Reilly JJ. Sources of graft restriction after single lung transplantation for emphysema. J Thorac Cardiovasc Surg 2007; 134:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/110\">",
"      Levine SM, Anzueto A, Gibbons WJ, et al. Graft position and pulmonary function after single lung transplantation for obstructive lung disease. Chest 1993; 103:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/111\">",
"      de Leval MR, Smyth R, Whitehead B, et al. Heart and lung transplantation for terminal cystic fibrosis. A 4 1/2-year experience. J Thorac Cardiovasc Surg 1991; 101:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/112\">",
"      Egan TM, Detterbeck FC, Mill MR, et al. Improved results of lung transplantation for patients with cystic fibrosis. J Thorac Cardiovasc Surg 1995; 109:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/113\">",
"      Egan TM. Lung transplantation in cystic fibrosis. Semin Respir Infect 1992; 7:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/114\">",
"      Dennis C, Caine N, Sharples L, et al. Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth Hospital. J Heart Lung Transplant 1993; 12:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/115\">",
"      Mendeloff EN, Huddleston CB, Mallory GB, et al. Pediatric and adult lung transplantation for cystic fibrosis. J Thorac Cardiovasc Surg 1998; 115:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/116\">",
"      Barlow CW, Robbins RC, Moon MR, et al. Heart-lung versus double-lung transplantation for suppurative lung disease. J Thorac Cardiovasc Surg 2000; 119:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/117\">",
"      Vricella LA, Karamichalis JM, Ahmad S, et al. Lung and heart-lung transplantation in patients with end-stage cystic fibrosis: the Stanford experience. Ann Thorac Surg 2002; 74:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/118\">",
"      Barr ML, Schenkel FA, Bowdish ME, Starnes VA. Living donor lobar lung transplantation: current status and future directions. Transplant Proc 2005; 37:3983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/119\">",
"      Meyers BF, Lynch JP, Trulock EP, et al. Single versus bilateral lung transplantation for idiopathic pulmonary fibrosis: a ten-year institutional experience. J Thorac Cardiovasc Surg 2000; 120:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/120\">",
"      Pasque MK, Trulock EP, Kaiser LR, Cooper JD. Single-lung transplantation for pulmonary hypertension. Three-month hemodynamic follow-up. Circulation 1991; 84:2275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/121\">",
"      Ritchie M, Waggoner AD, D&aacute;vila-Rom&aacute;n VG, et al. Echocardiographic characterization of the improvement in right ventricular function in patients with severe pulmonary hypertension after single-lung transplantation. J Am Coll Cardiol 1993; 22:1170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/122\">",
"      Pasque MK, Trulock EP, Cooper JD, et al. Single lung transplantation for pulmonary hypertension. Single institution experience in 34 patients. Circulation 1995; 92:2252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/123\">",
"      Kramer MR, Valantine HA, Marshall SE, et al. Recovery of the right ventricle after single-lung transplantation in pulmonary hypertension. Am J Cardiol 1994; 73:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/124\">",
"      Chapelier A, Vouh&eacute; P, Macchiarini P, et al. Comparative outcome of heart-lung and lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg 1993; 106:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/125\">",
"      Kasimir MT, Mereles D, Aigner C, et al. Assessment of pulmonary artery systolic pressures by stress Doppler echocardiography after bilateral lung transplantation. J Heart Lung Transplant 2008; 27:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/126\">",
"      Bando K, Armitage JM, Paradis IL, et al. Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg 1994; 108:1056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/127\">",
"      Levine SM, Gibbons WJ, Bryan CL, et al. Single lung transplantation for primary pulmonary hypertension. Chest 1990; 98:1107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/128\">",
"      Conte JV, Borja MJ, Patel CB, et al. Lung transplantation for primary and secondary pulmonary hypertension. Ann Thorac Surg 2001; 72:1673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/129\">",
"      Gorcsan J 3rd, Reddy SC, Armitage JM, Griffith BP. Acquired right ventricular outflow tract obstruction after lung transplantation: diagnosis by transesophageal echocardiography. J Am Soc Echocardiogr 1993; 6:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/130\">",
"      Schulman LL, Leibowitz DW, Anandarangam T, et al. Variability of right ventricular functional recovery after lung transplantation. Transplantation 1996; 62:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/131\">",
"      Kasimir MT, Seebacher G, Jaksch P, et al. Reverse cardiac remodelling in patients with primary pulmonary hypertension after isolated lung transplantation. Eur J Cardiothorac Surg 2004; 26:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/132\">",
"      Scuderi LJ, Bailey SR, Calhoon JH, et al. Echocardiographic assessment of right and left ventricular function after single-lung transplantation. Am Heart J 1994; 127:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/50/17194/abstract/133\">",
"      Fitton TP, Kosowski TR, Barreiro CJ, et al. Impact of secondary pulmonary hypertension on lung transplant outcome. J Heart Lung Transplant 2005; 24:1254.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4657 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-E57427EB1A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_50_17194=[""].join("\n");
var outline_f16_50_17194=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ANATOMIC CHANGES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      GENERAL PHYSIOLOGIC CHANGES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Airway reactivity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Cough reflex and mucociliary clearance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Control of breathing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Oropharyngeal dysphagia, gastroesophageal reflux, and gastroparesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Respiratory and skeletal muscle function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Sleep disordered breathing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      PULMONARY FUNCTION TESTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Spirometry",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Lung volumes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Gas transfer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Exercise function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Operation specific changes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      DISEASE SPECIFIC CHANGES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      COPD/emphysema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Cystic fibrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Interstitial lung diseases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Pulmonary arterial hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/4657\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4657|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/21/24923\" title=\"table 1\">",
"      Classification of BOS",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/25/18841?source=related_link\">",
"      Chronic lung transplant rejection: Bronchiolitis obliterans",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/4/40008?source=related_link\">",
"      Control of ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/40/23173?source=related_link\">",
"      Glucocorticoid-induced myopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/6/99?source=related_link\">",
"      Heart-lung transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/25/3480?source=related_link\">",
"      Lung transplantation: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/29/31192?source=related_link\">",
"      Lung transplantation: Disease-based choice of procedure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/50/38697?source=related_link\">",
"      Lung transplantation: Procedure and postoperative management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/56/24454?source=related_link\">",
"      Mechanisms and anatomic sites of upper airway obstruction in obstructive sleep apnea in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/60/12233?source=related_link\">",
"      Noninfectious complications following lung transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/47/19193?source=related_link\">",
"      Overview of pulmonary hypertension in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_50_17195="Presentation JSS";
var content_f16_50_17195=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F66446&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F66446&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Presenting signs and symptoms in children with systemic sclerosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Signs - symptoms",
"       </td>",
"       <td class=\"subtitle1\">",
"        Percent of patients (n = 164",
"patients)*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Skin tightening",
"       </td>",
"       <td>",
"        84",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Raynaud's phenomenon",
"       </td>",
"       <td>",
"        72",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Arthralgia",
"       </td>",
"       <td>",
"        32",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Muscle weakness and pain",
"       </td>",
"       <td>",
"        17",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Subcutaneous calcification",
"       </td>",
"       <td>",
"        10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dysphagia",
"       </td>",
"       <td>",
"        16",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dyspnea",
"       </td>",
"       <td>",
"        14",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Percentage calculated only on those series in which detailed information were provided.",
"    </div>",
"    <div class=\"reference\">",
"     Cumulative series from references Martini, G, et al. Arthritis Rheum 2003; Burge, SM, et al. JR Soc Med 1984; Larregue, M, et al. Ann Dermatol Venereol 1983; Su&Dagger;rez-Almazor, ME, et al. Arthritis Rheum 1985.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_50_17195=[""].join("\n");
var outline_f16_50_17195=null;
var title_f16_50_17196="Miscell cutaneous tox chemo";
var content_f16_50_17196=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F51026&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F51026&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Miscellaneous cutaneous reactions associated with chemotherapy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Condition",
"      </td>",
"      <td class=\"subtitle1\">",
"       Drugs",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Blistering disorder characterized as a paraneoplastic pemphigus-like phenomenon",
"      </td>",
"      <td>",
"       Fludarabine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Raynaud's phenomenon",
"      </td>",
"      <td>",
"       Bleomycin, vinblastine, vincristine, BEP, PVB, MOPP, ABVD",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Dermatomyositis-like reaction",
"      </td>",
"      <td>",
"       Hydroxyurea (chronic), tamoxifen, tegafur",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Folliculitis",
"      </td>",
"      <td>",
"       Dactinomycin, fluorouracil, methotrexate",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Porphyria",
"      </td>",
"      <td>",
"       Busulfan, chlorambucil, cisplatin, cyclophosphamide, methotrexate",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Telangiectasia",
"      </td>",
"      <td>",
"       Carmustine (topical), hydroxyurea, EGFR inhibitors",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lichenoid eruption",
"      </td>",
"      <td>",
"       Hydroxyurea, tegafur",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Inflammation of benign lesions",
"      </td>",
"      <td>",
"       Cisplatin, dacarbazine, dactinomycin, doxorubicin, fluorouracil, vincristine, capecitabine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Reactivation of Varicella-Zoster infection",
"      </td>",
"      <td>",
"       Bortezomib",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Eosinophilic cellulitis",
"      </td>",
"      <td>",
"       Cladribine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Histiocytic dermatosis",
"      </td>",
"      <td>",
"       Cytarabine, methotrexate",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Leg ulcers",
"      </td>",
"      <td>",
"       Hydroxyurea",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     BEP: bleomycin, etoposide, cisplatin; PVB: cisplatin, vinblastine, bleomycin; MOPP: mechlorethamine, vinblastine, procarbazine, prednisone; ABVD: doxorubicin, bleomycin, vinblastine, dacarbazine; EGFR: Epidermal growth factor receptor.",
"    </div>",
"    <div class=\"reference\">",
"     Modified from:",
"     <br>",
"      Susser, WS, et al. Mucocutaneous reactions to chemotherapy. J Am Acad Dermatol 1999; 40:367.",
"      <br>",
"       Rossini, MS, de Souza, EM, Cintra, ML, et al. Cutaneous adverse reaction to 2-chlorodeoxyadenosine with histological flame figures in patients with chronic lymphocytic leukaemia. Journal of the European Academy of Dermatology &amp; Venereology 2004; 18:538.",
"       <br>",
"        Boyd, AS. Histiocyte-rich dermatoses in two patients with acute lymphocytic leukaemia treated with cytarabine. Histopathology 2004; 45:194.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_50_17196=[""].join("\n");
var outline_f16_50_17196=null;
var title_f16_50_17197="NASCET endarterectomy stroke";
var content_f16_50_17197=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F75669&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F75669&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Benefit of carotid endarterectomy after recent ipsilateral nondisabling stroke or TIA in the NASCET trial",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 392px; height: 262px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The North American Symptomatic Carotid Endarterectomy Trial (NASCET)&nbsp;included 659 patients with a recent transient ischemic attack or nondisabling stroke and a 70 to 99 percent carotid stenosis who were randomly assigned to carotid endarterectomy or medical therapy. After a two year follow-up, the cumulative risk of any ipsilateral stroke was significantly lower in the endarterectomy group compared with the medical treatment group (9 versus 26 percent). The Kaplan-Meier survival curve shows the probability of event-free survival after randomization at six month intervals.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991; 325:445.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_50_17197=[""].join("\n");
var outline_f16_50_17197=null;
var title_f16_50_17198="Beta blocker Q wave NQWMI";
var content_f16_50_17198=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F79592&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F79592&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 479px\">",
"   <div class=\"ttl\">",
"    Beta blockers are equally effective after a Q wave or non-Q wave MI",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 459px; height: 311px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Analysis of data from 201,752 patients with a myocardial infarction (MI) demonstrates that the reduction in mortality at two years with beta blockers is similar in those with a Q wave (14.2 versus 23.6 percent for those not receiving beta blockers) or non-Q wave MI (14.4 versus 23.9 percent).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Gottlieb SS, McCarter RJ, Vogel RA. N Engl J Med 1998; 339:489.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_50_17198=[""].join("\n");
var outline_f16_50_17198=null;
var title_f16_50_17199="Calcaneus";
var content_f16_50_17199=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F80659&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F80659&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Calcaneus foot deformity",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 350px; height: 352px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of: Drs. Vineeta Swaroop and Luciano Dias.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_50_17199=[""].join("\n");
var outline_f16_50_17199=null;
